{"range": "VaxPublicationsONLY!A1:AB1313", "majorDimension": "ROWS", "values": [["", "", "article_title"], ["", "", "Neuro", "Neuro link"], ["Neuro", "Neuro - General", "General:"], ["Neuro", "Neuro - General", "Spectrum of neurological complications following COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8557950/", "https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8557950/"], ["Neuro", "Neuro - General", "Covid Vaccines are not free of Neurologic side effects:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206845/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206845/"], ["Neuro", "Neuro - General", "COVID-19 mRNA vaccination leading to CNS inflammation: a case series https://link.springer.com/article/10.1007/s00415-021-10780-7?fbclid=IwAR1WIozzELtGyD_DttkLNZFMcl3yW6iBW9C0v8uRyiYtTulzRvKVPE_xYko"], ["Neuro", "Neuro - General", "A systematic review of cases of CNS demyelination following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34839149/", " https://pubmed.ncbi.nlm.nih.gov/34839149/"], ["Neuro", "Neuro - General", "Spectrum of neuroimaging findings in post-covid-19 vaccination: a case series and review of the literature:\u00a0https://pubmed.ncbi.nlm.nih.gov/34842783/", "https://pubmed.ncbi.nlm.nih.gov/34842783/"], ["Neuro", "Neuro - General", "Neurologic autoimmune diseases following vaccinations:\u00a0https://pubmed.ncbi.nlm.nih.gov/34668274/", "https://pubmed.ncbi.nlm.nih.gov/34668274/"], ["Neuro", "Neuro - General", "New-onset autoimmune phenomena post COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34957554/                                                                                                                                                                                                        ", "https://pubmed.ncbi.nlm.nih.gov/34957554/"], ["Neuro", "Neuro - General", "Neurologic side effects of COVID-19 vaccinations:\u00a0https://pubmed.ncbi.nlm.nih.gov/34750810/", "https://pubmed.ncbi.nlm.nih.gov/34750810/"], ["Neuro", "Neuro - General", "Rebuttal about Functional Neurologic Disorders and Vaccination:https://onlinelibrary.wiley.com/doi/full/10.1002/ana.26160?fbclid=IwAR3C-QQc-ZDEDoCu0fWNQuVYzvbC3qYHGekCaicU5-l_bOUz4N52jl1wjJ0", "https://onlinelibrary.wiley.com/doi/full/10.1002/ana.26160?fbclid=IwAR3C-QQc-ZDEDoCu0fWNQuVYzvbC3qYHGekCaicU5-l_bOUz4N52jl1wjJ0"], ["Neuro", "Neuro - General", "Neurologic safety monitoring of COVID-19 vaccines, lessons learned from the past to inform the present:\u00a0https://pubmed.ncbi.nlm.nih.gov/34475124/", "https://pubmed.ncbi.nlm.nih.gov/34475124/"], ["Neuro", "Neuro - General", "Neurological side effects after first dose AstraZeneca and COVID-19 infection:\u00a0https://pubmed.ncbi.nlm.nih.gov/34697502/", "https://pubmed.ncbi.nlm.nih.gov/34697502/"], ["Neuro", "Neuro - General", "Combined central and peripheral demyelination with Anti-neurofascin155 IgG following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35107062/", "https://pubmed.ncbi.nlm.nih.gov/35107062/"], ["", "", "Neuropathy:"], ["Neuro", "Neuropathy", "Small fiber neuropathy:\u00a0https://onlinelibrary.wiley.com/doi/10.1002/mus.27251...\u00a0", "https://onlinelibrary.wiley.com/doi/10.1002/mus.27251?fbclid=IwAR1HGawxew4SJMoHonmJsMWpWh7Fdkh29191M84BsINLsNtOYj_R6oWqrTE"], ["Neuro", "Neuropathy", "COVID-19 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy: https://pubmed.ncbi.nlm.nih.gov/34525410/", "https://pubmed.ncbi.nlm.nih.gov/34525410/"], ["Neuro", "Neuropathy", "Possible mechanisms of neuropathies associated with covid-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35119106/", "https://pubmed.ncbi.nlm.nih.gov/35119106/"], ["Neuro", "Neuropathy", "Acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase: https://pubmed.ncbi.nlm.nih.gov/34579259/", "https://pubmed.ncbi.nlm.nih.gov/34579259/"], ["Neuro", "", "POTS:"], ["Neuro", "Pots", "POTS following Pfizer:\u00a0https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine", "https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine"], ["Neuro", "Pots", "Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine https://academic.oup.com/ehjcr/article/5/12/ytab472/6444985"], ["Neuro", "", "Neuralgia - Trigeminal, amytrophy:"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Trigeminal neuritis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34870807/", "https://pubmed.ncbi.nlm.nih.gov/34870807/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Trigeminal Neuralgia and cervical radiculitis after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34155020/", "https://pubmed.ncbi.nlm.nih.gov/34155020/?fbclid=IwAR1iZlmFR7OYHCbxkKoKs20y5ojvZtEgJFvv8D0Z96mLMXtIIBrIeZaFSn0"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Neuralgic amyotrophy following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34347105/", "https://pubmed.ncbi.nlm.nih.gov/34347105/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Amyotrophic neuralgia secondary to AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34330677/", "https://pubmed.ncbi.nlm.nih.gov/34330677/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Neuralgic amyotrophy of the lumbosacral plexus following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34816739/", "https://pubmed.ncbi.nlm.nih.gov/34816739/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Parsonage-Turner syndrome following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34559695/", "https://pubmed.ncbi.nlm.nih.gov/34559695/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Parsonage-Turner syndrome in a 43yoM after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34936579/", "https://pubmed.ncbi.nlm.nih.gov/34936579/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "2 cases of Parsonage Turner Syndrome following Moderna and Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34402669/", "https://pubmed.ncbi.nlm.nih.gov/34402669/"], ["Neuro", "Neuralgia - Trigeminal, amytrophy:", "Parsonage\u2014Turner syndrome following Astra Zeneca: a case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34903275/", "https://pubmed.ncbi.nlm.nih.gov/34903275/"], ["Neuro", "", "Transverse Myelitis:"], ["Neuro", "Transverse Myelitis:", "36yoM with transverse myelitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/33787891/", "https://pubmed.ncbi.nlm.nih.gov/33787891/"], ["Neuro", "Transverse Myelitis:", "Acute Myelitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34392078/", "https://pubmed.ncbi.nlm.nih.gov/34392078/"], ["Neuro", "Transverse Myelitis:", "67yoF with transverse myelitis following Moderna 1st\u00a0dose:\u00a0https://pubmed.ncbi.nlm.nih.gov/34482455/", "https://pubmed.ncbi.nlm.nih.gov/34482455/"], ["Neuro", "Transverse Myelitis:", "70yoM with acute autoimmune transverse myelitis following Moderna: https://pubmed.ncbi.nlm.nih.gov/34941191/", "https://pubmed.ncbi.nlm.nih.gov/34941191/"], ["Neuro", "Transverse Myelitis:", "Longitudinal extensive transverse myelitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34507942/", "https://pubmed.ncbi.nlm.nih.gov/34507942/"], ["Neuro", "Transverse Myelitis:", "Longitudinal extensive transverse myelitis in a 25yoF following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34641797/", "https://pubmed.ncbi.nlm.nih.gov/34641797/"], ["Neuro", "Transverse Myelitis:", "Longitudinal extensive transverse myelitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34182207/", "https://pubmed.ncbi.nlm.nih.gov/34182207/"], ["Neuro", "Transverse Myelitis:", "Acute transverse myelitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34684047/", "https://pubmed.ncbi.nlm.nih.gov/34684047/"], ["Neuro", "Transverse Myelitis:", "Transverse Myelitis and Bells Palsy after J&J vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34458035/", "https://pubmed.ncbi.nlm.nih.gov/34458035/"], ["Neuro", "Transverse Myelitis:", "Acute transverse myelitis in 43 patients post AstraZeneca Vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33981305/", "https://pubmed.ncbi.nlm.nih.gov/33981305/"], ["Neuro", "", "GBS:"], ["Neuro", "GBS", "12 cases of GBS and 4 cases of CIDP following COVID-19 vaccination in the UK: https://pubmed.ncbi.nlm.nih.gov/34786740/", "https://pubmed.ncbi.nlm.nih.gov/34786740/"], ["Neuro", "GBS", "24 cases of GBS following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34967005/", "https://pubmed.ncbi.nlm.nih.gov/34967005/"], ["Neuro", "GBS", "Sensory GBS in a 16yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35097156/", "https://pubmed.ncbi.nlm.nih.gov/35097156/"], ["Neuro", "GBS", "Sensory ataxic GBS with immunoglobulin G anti-GM1 antibodies following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34871447/", "https://pubmed.ncbi.nlm.nih.gov/34871447/"], ["Neuro", "GBS", "AstraZeneca and GBS: analysis using National Immunoglobulin Database: https://pubmed.ncbi.nlm.nih.gov/35180300/", "https://pubmed.ncbi.nlm.nih.gov/35180300/"], ["Neuro", "GBS", "GBS following Johnson and Johnson:\u00a0https://www.onlinescientificresearch.com/articles/the-development-of-guillain-barre-syndrome-subsequent-to-administration-of-ad26cov2s-vaccine.pdf", "https://www.onlinescientificresearch.com/articles/the-development-of-guillain-barre-syndrome-subsequent-to-administration-of-ad26cov2s-vaccine.pdf"], ["Neuro", "GBS", "GBS following 2nd\u00a0dose of Pfizer:, electromyoneurography and laboratory findings:\u00a0https://pubmed.ncbi.nlm.nih.gov/34347563/", "https://pubmed.ncbi.nlm.nih.gov/34347563/"], ["Neuro", "GBS", "GBS in a 25yoF following 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34346014/", "https://pubmed.ncbi.nlm.nih.gov/34346014/"], ["Neuro", "GBS", "GBS following Pfizer in a 42yoM\u00a0:\u00a0https://pubmed.ncbi.nlm.nih.gov/34779385/", "https://pubmed.ncbi.nlm.nih.gov/34779385/"], ["Neuro", "GBS", "GBS in a 42yoF following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34567447/", "https://pubmed.ncbi.nlm.nih.gov/34567447/"], ["Neuro", "GBS", "GBS in a 61yoM following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34484780/", "https://pubmed.ncbi.nlm.nih.gov/34484780/"], ["Neuro", "GBS", "GBS in a 65yoM liver transplant patient following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34431208/", "https://pubmed.ncbi.nlm.nih.gov/34431208/"], ["Neuro", "GBS", "GBS in a 67yoM following 1st\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34796417/", "https://pubmed.ncbi.nlm.nih.gov/34796417/"], ["Neuro", "GBS", "GBS in a 73yoM following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34477091/", "https://pubmed.ncbi.nlm.nih.gov/34477091/"], ["Neuro", "GBS", "GBS in 73yoM following 2nd\u00a0dose of Pfizer:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253659/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253659/"], ["Neuro", "GBS", "GBS in 82yoF following 1st\u00a0dose Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33758714/", "https://pubmed.ncbi.nlm.nih.gov/33758714/"], ["Neuro", "GBS", "GBS 10 days after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34272622/", "https://pubmed.ncbi.nlm.nih.gov/34272622/"], ["Neuro", "GBS", "GBS 11 days after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34187803/", "https://pubmed.ncbi.nlm.nih.gov/34187803/"], ["Neuro", "GBS", "GBS following AstraZeneca with papilledema as atypical onset:\u00a0https://pubmed.ncbi.nlm.nih.gov/34418708/", "https://pubmed.ncbi.nlm.nih.gov/34418708/"], ["Neuro", "GBS", "GBS following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34330729/", "https://pubmed.ncbi.nlm.nih.gov/34330729/"], ["Neuro", "GBS", "GBS in a 63yo patient who had previous vaccine associated GBS syndrome following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34810163/", "https://pubmed.ncbi.nlm.nih.gov/34810163/"], ["Neuro", "GBS", "Recurrent GBS following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34468703/", "https://pubmed.ncbi.nlm.nih.gov/34468703/"], ["Neuro", "GBS", "3 cases of GBS following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34548920/", "https://pubmed.ncbi.nlm.nih.gov/34548920/"], ["Neuro", "GBS", "3 cases of GBS and 1 case of CIDP following AstraZeneca in Tasmania:\u00a0https://pubmed.ncbi.nlm.nih.gov/34560365/", "https://pubmed.ncbi.nlm.nih.gov/34560365/"], ["Neuro", "GBS", "4 cases of GBS following Astra Zeneca", "4 cases of GBS following Astra Zeneca:"], ["Neuro", "GBS", "7 cases of GBS following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34114256/", "https://pubmed.ncbi.nlm.nih.gov/34114256/"], ["Neuro", "GBS", "19 cases of GBS following J&J, Pfizer, and Astra Zeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34644738/", "https://pubmed.ncbi.nlm.nih.gov/34644738/"], ["Neuro", "GBS", "GBS following vaccination, a review of 39 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/34648420/", "https://pubmed.ncbi.nlm.nih.gov/34648420/"], ["Neuro", "GBS", "2 cases of Sensory GBS following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34416410/", "https://pubmed.ncbi.nlm.nih.gov/34416410/"], ["Neuro", "GBS", "Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca:https://pubmed.ncbi.nlm.nih.gov/34261746/", "https://pubmed.ncbi.nlm.nih.gov/34261746/"], ["Neuro", "GBS", "Bifacial diplegia variant of GBS following J&J vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34449715/", "https://pubmed.ncbi.nlm.nih.gov/34449715/"], ["Neuro", "GBS", "GBS presenting as bifacial diplegia in 2 patients following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34649856/", "https://pubmed.ncbi.nlm.nih.gov/34649856/"], ["Neuro", "GBS", "GBS following Johnson and Johnson: https://pubmed.ncbi.nlm.nih.gov/34550109/", "https://pubmed.ncbi.nlm.nih.gov/34550109/"], ["Neuro", "GBS", "GBS following Moderna: https://pubmed.ncbi.nlm.nih.gov/34767184/", "https://pubmed.ncbi.nlm.nih.gov/34767184/"], ["Neuro", "GBS", "GBS following 1st dose AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34217513/", "https://pubmed.ncbi.nlm.nih.gov/34217513/"], ["Neuro", "GBS", "GBS with Prominent Facial Diplegia after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34808658/", "https://pubmed.ncbi.nlm.nih.gov/34808658/"], ["Neuro", "GBS", "GBS in a 14yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34717201/", "https://pubmed.ncbi.nlm.nih.gov/34717201/"], ["Neuro", "GBS", "GBS in a 21yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34981285/", "https://pubmed.ncbi.nlm.nih.gov/34981285/"], ["Neuro", "GBS", "GBS in a 38yoF following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34988954/", "https://pubmed.ncbi.nlm.nih.gov/34988954/"], ["Neuro", "GBS", "GBS in a 49yoF following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34703690/", "https://pubmed.ncbi.nlm.nih.gov/34703690/"], ["Neuro", "GBS", "2 cases of GBS following Pfizer in patients in remission from b-cell lymphoma: https://pubmed.ncbi.nlm.nih.gov/34929194/", "https://pubmed.ncbi.nlm.nih.gov/34929194/"], ["Neuro", "GBS", "2 cases of GBS after Pfizer and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34593364/", "https://pubmed.ncbi.nlm.nih.gov/34593364/"], ["Neuro", "GBS", "GBS following COVID-10 vaccination: a report of 2 cases: https://pubmed.ncbi.nlm.nih.gov/34599482/", "https://pubmed.ncbi.nlm.nih.gov/34599482/"], ["Neuro", "GBS", "Facial Diplegia variant of GBS in a 38yoM following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34538679/", "https://pubmed.ncbi.nlm.nih.gov/34538679/"], ["Neuro", "GBS", "Facial Diplegia variant of GBS in a 65yoF following J&J: https://pubmed.ncbi.nlm.nih.gov/34447646/", "https://pubmed.ncbi.nlm.nih.gov/34447646/"], ["Neuro", "GBS", "Axonal-variant GBS in 86yoF temporally associated with Moderna vaccination: https://pubmed.ncbi.nlm.nih.gov/34722067/", "https://pubmed.ncbi.nlm.nih.gov/34722067/"], ["Neuro", "", "Miller Fisher Syndrome:"], ["Neuro", "Miller Fisher Syndrome", "Miller Fischer syndrome and GBS overlap syndrome after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34848426/", "https://pubmed.ncbi.nlm.nih.gov/34848426/"], ["Neuro", "Miller Fisher Syndrome", "Miller Fisher syndrome in 24yoF following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34817727/", "https://pubmed.ncbi.nlm.nih.gov/34817727/"], ["Neuro", "Miller Fisher Syndrome", "Miller Fisher Syndrome in a 71yoM following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34789193/", "https://pubmed.ncbi.nlm.nih.gov/34789193/"], ["Neuro", "Miller Fisher Syndrome", "Miller Fisher syndrome after 2nd\u00a0dose of Pfizer vaccination in a patient with resolved covid-19", "Miller Fisher syndrome after 2nd\u00a0dose of Pfizer vaccination in a patient with resolved covid-19:\u00a0https://pubmed.ncbi.nlm.nih.gov/34808657/https://journals.lww.com/jcnmd/Citation/2021/12000/Miller_Fisher_Syndrome_Presenting_After_a_Second.10.aspx"], ["Neuro", "", "Encephalopathy:"], ["Neuro", "Encephalopathy", "75yoF with acute hemorrhagic necrotizing encephalopathy after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35098489/", "https://pubmed.ncbi.nlm.nih.gov/35098489/"], ["Neuro", "Encephalopathy", "3 cases of acute hemorrhagic encephalomyelitis after AstraZeneca: https://pubmed."], ["Neuro", "Encephalopathy", "32yoM with acute hyperactive encephalopathy after Moderna with dramatic response to methylprednisolone: https://pubmed.ncbi.nlm.nih.gov/34512961/", "https://pubmed.ncbi.nlm.nih.gov/34512961/"], ["Neuro", "Encephalopathy", "Facial Weakness, extremity weakness, encephalopathy, and severe refractory ITP following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/33854395/", "https://pubmed.ncbi.nlm.nih.gov/33854395/"], ["Neuro", "Encephalopathy", "77yoM with acute encephalopathy and NSTEMI following Moderna: https://pubmed.ncbi.nlm.nih.gov/34703815/", "https://pubmed.ncbi.nlm.nih.gov/34703815/"], ["Neuro", "", "CIDP:"], ["Neuro", "CIDP", "CIPD in a middle aged female following Moderna: https://pubmed.ncbi.nlm.nih.gov/35071987/", "https://pubmed.ncbi.nlm.nih.gov/35071987/"], ["Neuro", "CIDP", "Acute onset chronic inflammatory demyelinating polyneuropathy (CIDP) after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34607818/", "https://pubmed.ncbi.nlm.nih.gov/34607818/"], ["Neuro", "CIDP", "Chronic inflammatory\u00a0demyelinating polyneuropathy after AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34960248/", "https://pubmed.ncbi.nlm.nih.gov/34960248/"], ["Neuro", "", "Akathisia:"], ["Neuro", "Akathisia", "Transient akathisia after Pfizer", "Transient akathisia after Pfizer:"], ["Neuro", "", "Phantosmia:\u00a0"], ["Neuro", "Phantosmia", "Phantosmia:\u00a0https://pubmed.ncbi.nlm.nih.gov/34096896/", "https://pubmed.ncbi.nlm.nih.gov/34096896/"], ["Neuro", "", "Bells Palsy / Nerve Palsy:"], ["Neuro", "Bells Palsy / Nerve Palsy", "Multiple cranial nerve palsies following COVID-19 vaccination (Pfizer): https://pubmed.ncbi.nlm.nih.gov/34725821/", "https://pubmed.ncbi.nlm.nih.gov/34725821/"], ["Neuro", "Bells Palsy / Nerve Palsy", "Acute abducens nerve palsy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34044114/", "https://pubmed.ncbi.nlm.nih.gov/34044114/"], ["Neuro", "Bells Palsy / Nerve Palsy", "Acute aducens nerve palsy following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34851785/", "https://pubmed.ncbi.nlm.nih.gov/34851785/"], ["Neuro", "Bells Palsy / Nerve Palsy", "Acute Abducens nerve palsy following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34827043/", "https://pubmed.ncbi.nlm.nih.gov/34827043/"], ["Neuro", "Bells Palsy / Nerve Palsy", "21yoF nurse with Bells Palsy following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34322761/", "https://pubmed.ncbi.nlm.nih.gov/34322761/"], ["Neuro", "Bells Palsy / Nerve Palsy", "34yoF with Bells Palsy 2 days after Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143982/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143982/"], ["Neuro", "Bells Palsy / Nerve Palsy", "36yo with Bells Palsy, left arm tingling/numbness/weakness following mRNA vaccination:https://pubmed.ncbi.nlm.nih.gov/34336436/", "https://pubmed.ncbi.nlm.nih.gov/34336436/"], ["Neuro", "Bells Palsy / Nerve Palsy", "37yoM with Bells Palsy after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33611630/", "https://pubmed.ncbi.nlm.nih.gov/33611630/"], ["Neuro", "Bells Palsy / Nerve Palsy", "50yoM with Bells Palsy after Pfizer, ongoing symptoms after 21 days:\u00a0https://pubmed.ncbi.nlm.nih.gov/34330676/", "https://pubmed.ncbi.nlm.nih.gov/34330676/"], ["Neuro", "Bells Palsy / Nerve Palsy", "57yoF with Bells Palsy <36 hours after 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33594349/", "https://pubmed.ncbi.nlm.nih.gov/33594349/"], ["Neuro", "Bells Palsy / Nerve Palsy", "61yoM with Bells Palsy after each dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34281950/", "https://pubmed.ncbi.nlm.nih.gov/34281950/"], ["Neuro", "Bells Palsy / Nerve Palsy", "Bells Palsy following mRNA and inactivated (CoronaVac) vaccines: a case series and nested case-control study:\u00a0https://pubmed.ncbi.nlm.nih.gov/34411532/", "https://pubmed.ncbi.nlm.nih.gov/34411532/"], ["Neuro", "Bells Palsy / Nerve Palsy", "Rate of Bells Palsy following mRNA vaccination is 2-3x higher then expected:\u00a0https://pubmed.ncbi.nlm.nih.gov/34111409/", "https://pubmed.ncbi.nlm.nih.gov/34111409/"], ["Neuro", "", "NMOSD:"], ["Neuro", "NMOSD", "New onset neuromyelitis optica spectrum disorder following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35184119/", "https://pubmed.ncbi.nlm.nih.gov/35184119/"], ["Neuro", "NMOSD", "Neuromyelitis optic in a healthy female following Moderna: https://pubmed.ncbi.nlm.nih.gov/34660149/", "https://pubmed.ncbi.nlm.nih.gov/34660149/"], ["Neuro", "NMOSD", "Neuromyelitis optica spectrum disorder (NMOSD):\u00a0https://link.springer.com/article/10.1007/s10072-021-05427-4?fbclid=IwAR2DGcW8Y5UxvdzcOQaBUPn6_RTZGQRSsNo6bzanyAm9yN6387E3Z6WrKlI", "https://link.springer.com/article/10.1007/s10072-021-05427-4?fbclid=IwAR2DGcW8Y5UxvdzcOQaBUPn6_RTZGQRSsNo6bzanyAm9yN6387E3Z6WrKlI"], ["Neuro", "NMOSD", "Optic neuropathy after Pfizer and Astrazeneca: a report of 2 cases: https://pubmed.ncbi.nlm.nih.gov/34906029/", "https://pubmed.ncbi.nlm.nih.gov/34906029/"], ["Neuro", "NMOSD", "Bilateral optic neuritis after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35098359/", "https://pubmed.ncbi.nlm.nih.gov/35098359/"], ["Neuro", "NMOSD", "Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205198/        https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205198/                                                                                                                                                                                                "], ["Neuro", "", "Multiple Sclerosis:"], ["Neuro", "Multiple Sclerosis:", "Patient\u2019s first MS Flare following Pfizer", "Patient\u2019s first MS Flare following Pfizer:"], ["Neuro", "Multiple Sclerosis:", "New onset MS in a 32yoF patient following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804388/", "https://pubmed.ncbi.nlm.nih.gov/34804388/"], ["Neuro", "Multiple Sclerosis:", "New onset of MS in a 40yoF following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34700047/", "https://pubmed.ncbi.nlm.nih.gov/34700047/"], ["Neuro", "Multiple Sclerosis:", "3 new cases of MS, 13 flares of MS after Pfizer, Moderna, and Astra Zeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34744992/", "https://pubmed.ncbi.nlm.nih.gov/34744992/"], ["Neuro", "Multiple Sclerosis:", "4 cases of activation of stable MS, 2 cases of new MS, 1 case of new onset neuromyelitis optica after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34480607/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34480607/"], ["Neuro", "Multiple Sclerosis:", "Severe Multiple Sclerosis relapse after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34447349/", "https://pubmed.ncbi.nlm.nih.gov/34447349/"], ["Neuro", "Multiple Sclerosis:", "5 cases of new diagnosis of multiple sclerosis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34922126/                                                                                                                                                                                                        ", "https://pubmed.ncbi.nlm.nih.gov/34922126/"], ["Neuro", "Multiple Sclerosis:", "Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205198/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205198/"], ["Neuro", "", "Myasthenia Gravis:"], ["Neuro", "Myasthenia Gravis:", "Vaccination associated Ocular Myasthenia Gravis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35077038/", "https://pubmed.ncbi.nlm.nih.gov/35077038/"], ["Neuro", "Myasthenia Gravis:", "Myasthenia Gravis Flare Following Moderna:\u00a0https://www.cureus.com/articles/60348-a-case-of-covid-19-vaccine-causing-a-myasthenia-gravis-crisis", "https://www.cureus.com/articles/60348-a-case-of-covid-19-vaccine-causing-a-myasthenia-gravis-crisis"], ["Neuro", "Myasthenia Gravis:", "New onset Myasthenia Gravis in 82yoM following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34709075/", "https://pubmed.ncbi.nlm.nih.gov/34709075/"], ["", "", "Cerebral Venous Thrombosis:"], ["", "Cerebral Venous Thrombosis:", "Thromboembolic events following mRNA COVID vaccination, a case series:https://pubmed.ncbi.nlm.nih.gov/35118582/", "https://pubmed.ncbi.nlm.nih.gov/35118582/"], ["", "Cerebral Venous Thrombosis:", "CVA and Thrombocytopenia following Astrazeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34175640/", "https://pubmed.ncbi.nlm.nih.gov/34175640/"], ["", "Cerebral Venous Thrombosis:", "Cerebral venous sinus thrombosis after Moderna in a 56yoF: https://pubmed.ncbi.nlm.nih.gov/35181646/", "https://pubmed.ncbi.nlm.nih.gov/35181646/"], ["", "Cerebral Venous Thrombosis:", "Cerebral venous thrombosis in a 61yoM following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34796065/", "https://pubmed.ncbi.nlm.nih.gov/34796065/"], ["", "Cerebral Venous Thrombosis:", "Cerebral venous sinus thrombosis after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34783932/", "https://pubmed.ncbi.nlm.nih.gov/34783932/"], ["", "Cerebral Venous Thrombosis:", "Central venous sinus thrombosis with subarachnoid hemorrhage in a 45yoM following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34478433/", "https://pubmed.ncbi.nlm.nih.gov/34478433/"], ["", "Cerebral Venous Thrombosis:", "Cerebral venous thrombosis and pulmonary embolus following AstraZeneca:\u00a0https://www.sciencedirect.com/.../pii/S0196064421003425", "https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.sciencedirect.com%2F...%2Fpii%2FS0196064421003425%3Ffbclid%3DIwAR1fj5YAs279VLhJZbXsyKTrXw_GFnEHtL-F-HO56KyZMeNTqquty0U-sqs&h=AT0vFf-rCXdIamrFySe5zWtPsRpxOuizJ9BdNezb0m6fxs7N7WBw_xueoCNE_Fj0ZucY1K-_hY_6Ypz4Use5A22ncBgqVhOMMuGcMZDfFnF2PjzY_gaV_oxBmnRQRzTj8cjgaU1ixCEBjl7qoTp02A&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "Cerebral Venous Thrombosis:", "Cerebral venous sinus thrombosis after AstraZeneca, neurologic and radiological management:\u00a0https://pubmed.ncbi.nlm.nih.gov/34327553/", "https://pubmed.ncbi.nlm.nih.gov/34327553/"], ["", "Cerebral Venous Thrombosis:", "Cerebral venous sinus thrombosis, subarachnoid hemorrhage, and thrombocytopenia following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34485807/", "https://pubmed.ncbi.nlm.nih.gov/34485807/"], ["", "Cerebral Venous Thrombosis:", "Cerebral Venous sinus thrombosis, review of European cases:\u00a0\u00a0https://pubmed.ncbi.nlm.nih.gov/34293217/", "https://pubmed.ncbi.nlm.nih.gov/34293217/"], ["", "Cerebral Venous Thrombosis:", "Review of European data of Cerebral venous thrombosis with cytopenia, observed in Pfizer, Moderna, and AstraZeneca\u00a0https://pubmed.ncbi.nlm.nih.gov/34375510/", "https://pubmed.ncbi.nlm.nih.gov/34375510/"], ["", "Cerebral Venous Thrombosis:", "A multicenter cohort study of cerebral venous thrombosis after AstraZeneca Vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34370972/", "https://pubmed.ncbi.nlm.nih.gov/34370972/"], ["", "Cerebral Venous Thrombosis:", "Endovascular treatment for AstraZeneca induced cerebral venous sinus thrombosis and thrombocytopenia, a report of 3 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/34782400/", "https://pubmed.ncbi.nlm.nih.gov/34782400/"], ["", "Cerebral Venous Thrombosis:", "45 cases of Cerebral Venous thrombosis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34288044/", "https://pubmed.ncbi.nlm.nih.gov/34288044/"], ["", "Cerebral Venous Thrombosis:", "International Cerebral Venous Thrombosis consortium report on cerebral venous thrombosis following vaccination against SARS-COV-2:\u00a0https://pubmed.ncbi.nlm.nih.gov/34462996/", "https://pubmed.ncbi.nlm.nih.gov/34462996/"], ["", "Cerebral Venous Thrombosis:", "Spontaneous rare visceral pseudoaneurysm presenting with rupture after Moderna:https://pubmed.ncbi.nlm.nih.gov/34480824/", "https://pubmed.ncbi.nlm.nih.gov/34480824/"], ["", "", "Intracerebral Hemorage / Strokes / etc:"], ["", "Intracerebral Hemorrhage / Strokes / etc:", "Fatal ICH following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34477089/", "https://pubmed.ncbi.nlm.nih.gov/34477089/"], ["", "Intracerebral Hemorrhage / Strokes / etc:", "ICH due to vasculitis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34783899/", "https://pubmed.ncbi.nlm.nih.gov/34783899/"], ["", "Intracerebral Hemorrhage / Strokes / etc:", "Treatment of AstraZeneca induced immume thrombotic thrombocytopenia related acute ischemic stroke:\u00a0https://pubmed.ncbi.nlm.nih.gov/34461442/", "https://pubmed.ncbi.nlm.nih.gov/34461442/"], ["", "Intracerebral Hemorrhage / Strokes / etc:", "Symptomatic penducular, cavernous bleeding following Pfizer vaccination induced ITP:https://pubmed.ncbi.nlm.nih.gov/34549178/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34549178/"], ["", "Intracerebral Hemorrhage / Strokes / etc:", "Lobar bleeding\u00a0with ventricular rupture shortly following mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34729467/", "https://pubmed.ncbi.nlm.nih.gov/34729467/"], ["", "Intracerebral Hemorrhage / Strokes / etc:", "Bilateral thalamic stroke following Pfizer: a case of VITT?\u00a0https://pubmed.ncbi.nlm.nih.gov/34820232/", "https://pubmed.ncbi.nlm.nih.gov/34820232/"], ["", "", "Aphasia:"], ["", "Aphasia", "Aphasia 7 days\u00a0after 2nd\u00a0dose of mRNA based vaccine due to intracerebral bleeding in left temporal lobe:\u00a0https://pubmed.ncbi.nlm.nih.gov/34192245/", "https://pubmed.ncbi.nlm.nih.gov/34192245/"], ["", "", "Neuro-Oncologic :"], ["", "Neuro-Oncologic", "Worsening Neuro-Oncologic Disease Symptoms following mRNA vaccination:\u00a0https://www.cureus.com/articles/61880-new-onset-neurologic-symptoms-and-related-neuro-oncologic-lesions-discovered-after-covid-19-vaccination-two-neurosurgical-cases-and-review-of-post-vaccine-inflammatory-responses", "https://www.cureus.com/articles/61880-new-onset-neurologic-symptoms-and-related-neuro-oncologic-lesions-discovered-after-covid-19-vaccination-two-neurosurgical-cases-and-review-of-post-vaccine-inflammatory-responses"], ["", "", "Headache / Aseptic Menengitis:"], ["", "Headache / Aseptic Menengitis", "18yoM with aseptic meningitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34711784/", "https://pubmed.ncbi.nlm.nih.gov/34711784/"], ["", "Headache / Aseptic Menengitis", "Aseptic meningitis in a 34yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34882515/", "https://pubmed.ncbi.nlm.nih.gov/34882515/"], ["", "Headache / Aseptic Menengitis", "Headache after AstraZeneca: a MultiCenter observational cohort center:\u00a0https://pubmed.ncbi.nlm.nih.gov/34313952/", "https://pubmed.ncbi.nlm.nih.gov/34313952/"], ["", "Headache / Aseptic Menengitis", "Status migrainosus following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34807361/", "https://pubmed.ncbi.nlm.nih.gov/34807361/"], ["", "Headache / Aseptic Menengitis", "Characteristics of COVID vaccine induced Headache:\u00a0https://pubmed.ncbi.nlm.nih.gov/34510919/", "https://pubmed.ncbi.nlm.nih.gov/34510919/"], ["", "Headache / Aseptic Menengitis", "Clinical characteristics of Headache following Pfizer, a multicenter observational cohort study:\u00a0https://pubmed.ncbi.nlm.nih.gov/34405142/", "https://pubmed.ncbi.nlm.nih.gov/34405142/"], ["", "Headache / Aseptic Menengitis", "Aseptic Meningitis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34378098/", "https://pubmed.ncbi.nlm.nih.gov/34378098/"], ["", "Headache / Aseptic Menengitis", "Aseptic meningitis after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34777795/", "https://pubmed.ncbi.nlm.nih.gov/34777795/"], ["", "Headache / Aseptic Menengitis", "Steroid responsive aseptic meningitis after Pfizer in a 62yoF:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566612/\u00a0", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566612/"], ["", "", "Encephalitis / Delirium:"], ["", "Encephalitis / Delirium", "Delirium in an elderly patient following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33829614/", "https://pubmed.ncbi.nlm.nih.gov/33829614/"], ["", "Encephalitis / Delirium", "Two cases of encephalopathy and seizures following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34367780/", "https://pubmed.ncbi.nlm.nih.gov/34367780/"], ["", "Encephalitis / Delirium", "Acute disseminated encephalitis following Pfizer:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294707/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294707/"], ["", "Encephalitis / Delirium", "Acute disseminated encephalomyelitis (ADEM) following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34735684/", "https://pubmed.ncbi.nlm.nih.gov/34735684/"], ["", "Encephalitis / Delirium", "ADEM with bilateral optic neuritis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35151258/", "https://pubmed.ncbi.nlm.nih.gov/35151258/"], ["", "Encephalitis / Delirium", "Acute disseminated encephalomyelitis (ADEM) in a 88yoF following Pfizer vaccination:https://pubmed.ncbi.nlm.nih.gov/34841097/", "https://pubmed.ncbi.nlm.nih.gov/34841097/"], ["", "Encephalitis / Delirium", "COVID-19 Moderna booster induced autoimmune encephalitis in a 48yoM: https://pubmed.ncbi.nlm.nih.gov/35182374/", "https://pubmed.ncbi.nlm.nih.gov/35182374/"], ["", "Encephalitis / Delirium", "Anti-LGI1 encephalitis in a 48yoM following mRNA vaccination: https://pubmed."], ["", "Encephalitis / Delirium", "Autoimmune encephalitis in a 35yoF following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35021289/", "https://pubmed.ncbi.nlm.nih.gov/35021289/"], ["", "Encephalitis / Delirium", "Case report of AstraZeneca associated encephalitis in a 22yoF: https://pubmed.ncbi.nlm.nih.gov/34903200/   ", "https://pubmed.ncbi.nlm.nih.gov/34903200/"], ["", "Encephalitis / Delirium", "Acute Disseminated Encephalitis in a young female following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34480527/", "https://pubmed.ncbi.nlm.nih.gov/34480527/"], ["", "Encephalitis / Delirium", "Postvaccinal encephalitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34324214/", "https://pubmed.ncbi.nlm.nih.gov/34324214/"], ["", "Encephalitis / Delirium", "Acute encephalitis, myoclonus, and sweet syndrome after mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34312136/", "https://pubmed.ncbi.nlm.nih.gov/34312136/"], ["", "Encephalitis / Delirium", "Acute psychosis due to anti-NMDA encephalitis in a young female in her 20s following Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34803896/", "https://pubmed.ncbi.nlm.nih.gov/34803896/"], ["", "Encephalitis / Delirium", "First episode of psychosis in 18yoF following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35091388/", "https://pubmed.ncbi.nlm.nih.gov/35091388/"], ["", "Encephalitis / Delirium", "New onset psychosis in 31yoM after mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34388513/", "https://pubmed.ncbi.nlm.nih.gov/34388513/"], ["", "", "Other:"], ["", "Parkinson's", "COVID-19 vaccine associated parkinson\u2019s disease, a prion disease signal in UK yellow card adverse event database: https://www.semanticscholar.org/paper/COVID-19-Vaccine-Associated-Parkinson%27s-Disease%2C-A-Classen/0fe033bb1e274f27bc7c1703f09206e2965c75ca"], ["", "Prion disease", "COVID-19 RNA based vaccines and the risk of prion disease: https://www.semanticscholar.org/paper/COVID-19-RNA-Based-Vaccines-and-the-Risk-of-Prion-Classen/68580738ad152158a095c2f90a2a28a4c8b5d7d2"], ["", "Other", "Polyneuritis cranialis, a rare GBS variant, associated with Pfizer in a 16yoF: https://pubmed.ncbi.nlm.nih.gov/35062795/", "https://pubmed.ncbi.nlm.nih.gov/35062795/"], ["", "Other", "Reversible radiculomyelitis after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35110289/", "https://pubmed.ncbi.nlm.nih.gov/35110289/"], ["", "Other", "Severe dyskinesia in Parkinson Patient following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34368991/", "https://pubmed.ncbi.nlm.nih.gov/34368991/"], ["", "Other", "Hemichorea following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34811599/", "https://pubmed.ncbi.nlm.nih.gov/34811599/"], ["", "Other", "3 cases of worsening complex regional pain syndrome following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34809486/", "https://pubmed.ncbi.nlm.nih.gov/34809486/"], ["", "Other", "Cytotoxic lesion of the Corpus Callousum following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34402238/", "https://pubmed.ncbi.nlm.nih.gov/34402238/"], ["", "Other", "Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34432055/", "https://pubmed.ncbi.nlm.nih.gov/34432055/"], ["", "Other", "Two patients with schizophrenia treated with clozapine develop neutropenia after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/35115846/", "https://pubmed.ncbi.nlm.nih.gov/35115846/"], ["", "Other", "Three cases: CVA, left facial nerve palsy, and myelitis all following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34507266/", "https://pubmed.ncbi.nlm.nih.gov/34507266/"], [], ["Pulmonary", "Pulmonary - General", "Pulmonary", "Pulmonary:"], ["Pulmonary", "Pulmonary - General", "Vaccine induced interstitial lung disease in 86yoM after mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34362838/", "https://pubmed.ncbi.nlm.nih.gov/34362838/"], ["Pulmonary", "Pulmonary - General", "Vaccine induced interstitial lung disease:\u00a0https://pubmed.ncbi.nlm.nih.gov/34510014/", "https://pubmed.ncbi.nlm.nih.gov/34510014/"], ["Pulmonary", "Pulmonary - General", "Delayed hypersensitivity to Pfizer presenting with pneumonitis and rash:\u00a0https://pubmed.ncbi.nlm.nih.gov/34813953/", "https://pubmed.ncbi.nlm.nih.gov/34813953/"], ["Pulmonary", "Pulmonary - General", "2 cases of eosinophilic pneumonia following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34803208/", "https://pubmed.ncbi.nlm.nih.gov/34803208/"], ["Pulmonary", "Pulmonary - General", "Interstitial lung disease after COVID-19 vaccination may be more common in Asians: https://pubmed.ncbi.nlm.nih.gov/34850213/", "https://pubmed.ncbi.nlm.nih.gov/34850213/"], ["Pulmonary", "Pulmonary - General", "Acute eosinophilic pneumonia in a 37yo M following Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34803207/", "https://pubmed.ncbi.nlm.nih.gov/34803207/"], ["Pulmonary", "Pulmonary - General", "Acute eosinophilic pneumonia following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34812326/", "https://pubmed.ncbi.nlm.nih.gov/34812326/"], ["Pulmonary", "Pulmonary - General", "Pulmonary Embolus following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34452028/", "https://pubmed.ncbi.nlm.nih.gov/34452028/"], ["Pulmonary", "Pulmonary - General", "2 cases of Pulmonary embolus following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804412/", "https://pubmed.ncbi.nlm.nih.gov/34804412/"], [], ["", "", "Cardiac: ", "Cardiac:"], ["", "", "General:"], ["", "", "Cardiovascular and hematological events post COVID-19 vaccination: a systemic review: https://pubmed.ncbi.nlm.nih.gov/34967105/", "https://pubmed.ncbi.nlm.nih.gov/34967105/"], ["", "", "American Heart Association: Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults"], ["", "", "American Heart Association: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines"], ["", "", "Note the distinction between myocarditis, novel coronavirus myocarditis, and covid-19 vaccine associated myocarditis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34791441/", "https://pubmed.ncbi.nlm.nih.gov/34791441/"], ["", "", "JAMA article, concerns for perimyocarditis underreporting, review of 40 hospitals:\u00a0https://jamanetwork.com/journals/jama/fullarticle/2782900", "https://jamanetwork.com/journals/jama/fullarticle/2782900"], ["", "", "Intravenous injection of mRNA vaccine can induce acute myopericarditis in mouse model:\u00a0https://pubmed.ncbi.nlm.nih.gov/34406358/", "https://pubmed.ncbi.nlm.nih.gov/34406358/"], ["", "", "The Novel platform of mRNA vaccines and myocarditis: clues into the potential underlying mechanism:\u00a0https://pubmed.ncbi.nlm.nih.gov/34312010/", "https://pubmed.ncbi.nlm.nih.gov/34312010/"], ["", "", "Proposed pathogenesis, characteristics, and management of mRNA related myopericarditis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34817850/", "https://pubmed.ncbi.nlm.nih.gov/34817850/"], ["", "", "mRNA and Pericarditis/myocarditis risk compared to other vaccine types:\u00a0https://pubmed.ncbi.nlm.nih.gov/34834458/", "https://pubmed.ncbi.nlm.nih.gov/34834458/"], ["", "", "ACS risk factor biomarkers increase after mRNA vaccination:\u00a0https://www.thecardiologyadvisor.com/home/topics/acs/acute-coronary-syndrome-acs-biomarkers-mrna-covid19-vaccine/?s=09&fbclid=IwAR2SRmzW0Aj1dESMuJlTTcZHAHbRIIdl6C2Hpztm8Co_46AV5qss_4-3NV8", "https://www.thecardiologyadvisor.com/home/topics/acs/acute-coronary-syndrome-acs-biomarkers-mrna-covid19-vaccine/?s=09&fbclid=IwAR2SRmzW0Aj1dESMuJlTTcZHAHbRIIdl6C2Hpztm8Co_46AV5qss_4-3NV8"], ["", "", "A review of cardiac side effects from Pfizer and Moderna in Singapore:\u00a0https://pubmed.ncbi.nlm.nih.gov/34808708/", "https://pubmed.ncbi.nlm.nih.gov/34808708/"], ["", "", "Fatal fulminant necrotizing eosinophilicy myocarditis following 1st dose Pfizer: https://pubmed.ncbi.nlm.nih.gov/34978002/", "https://pubmed.ncbi.nlm.nih.gov/34978002/"], ["", "", "Immune mediated necrotizing myopathy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34970746/", "https://pubmed.ncbi.nlm.nih.gov/34970746/"], ["", "", "Severe necrotizing myopathy after Pfizer and regimen of ipulimumab plus nivolumab in a patient with advanced melanoma: https://pubmed.ncbi.nlm.nih.gov/34661938/", "https://pubmed.ncbi.nlm.nih.gov/34661938/"], ["", "", "Myocarditis - Pericarditis - Reports:"], ["", "", "Biopsy proven fulminant myocarditis in a 48yoF following 2nd dose Moderna: https://pubmed.ncbi.nlm.nih.gov/35187464/", "https://pubmed.ncbi.nlm.nih.gov/35187464/"], ["", "", "Fulminant myocarditis in a 80yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35088026/", "https://pubmed.ncbi.nlm.nih.gov/35088026/"], ["", "", "8 cases of myocarditis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34133884/", "https://pubmed.ncbi.nlm.nih.gov/34133884/"], ["", "", "COVID-19 vaccine, myocardial infarction, and Kounis syndrome: https://pubmed.ncbi.nlm.nih.gov/35104343/", "https://pubmed.ncbi.nlm.nih.gov/35104343/"], ["", "", "Myocarditis in a 17yoM following vaccination: https://pubmed.ncbi.nlm.nih.gov/35105392/", "https://pubmed.ncbi.nlm.nih.gov/35105392/"], ["", "", "4 cases of myocarditis following Pfizer booster in Israel: https://pubmed.ncbi.nlm.nih.gov/35100809/", "https://pubmed.ncbi.nlm.nih.gov/35100809/"], ["", "", "Moderna associated myopericarditis in a patient with a subclinical autoimmune predisposition: https://pubmed.ncbi.nlm.nih.gov/34868402/", "https://pubmed.ncbi.nlm.nih.gov/34868402/"], ["", "", "Perimyocarditis in teens:\u00a0https://pubmed.ncbi.nlm.nih.gov/34077949/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34077949%2F%3Ffbclid%3DIwAR1xS66c_vkHZQPBHewPEhlzuncgd1N-4UUsjSHpZNUoXaBdCbQBYe7HXow&h=AT1YzmC73Je73TsqsG9wiZUdN3VHYx2UQDkgvwO9g1uDVq7jsVVc5pLRMv8rgMTRWLYpCl6zA0OV__h765WbrT_0QBG97nIeL9T16WtEhyLb4U79c7R5xP-9mA332QNwLdduEoVi_Ht_Z8WxhiSMHg&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Vaccination associated myocarditis in Adolescents:\u00a0https://pubmed.ncbi.nlm.nih.gov/34389692/", "https://pubmed.ncbi.nlm.nih.gov/34389692/"], ["", "", "mRNA vaccination and myocarditis in adolescents:\u00a0https://pubmed.ncbi.nlm.nih.gov/34393110/", "https://pubmed.ncbi.nlm.nih.gov/34393110/"], ["", "", "Association of myocarditis with mRNA vaccination, a case review in children:\u00a0https://pubmed.ncbi.nlm.nih.gov/34374740/", "https://pubmed.ncbi.nlm.nih.gov/34374740/"], ["", "", "STEMI mimic: focal myocarditis in an adolescent patient after mRNA COVID-19 vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34756746/", "https://pubmed.ncbi.nlm.nih.gov/34756746/"], ["", "", "Recurrence of myocarditis after vaccination", "Recurrence of myocarditis after vaccination:"], ["", "", "Acute Myocardial Injury following COVID-19 vaccination: a case report and review of current evidence from VAERS: https://pubmed.ncbi.nlm.nih.gov/34219532/"], ["", "", "Myopericarditis in young adults presenting to the ED:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310793/", "https://pubmed.ncbi.nlm.nih.gov/34310793/"], ["", "", "Pericarditis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34364831/", "https://pubmed.ncbi.nlm.nih.gov/34364831/"], ["", "", "Symptomatic pericarditis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34693198/", "https://pubmed.ncbi.nlm.nih.gov/34693198/"], ["", "", "Myocarditis following J&J in a healthy, young male:\u00a0https://pubmed.ncbi.nlm.nih.gov/34420869/", "https://pubmed.ncbi.nlm.nih.gov/34420869/"], ["", "", "Acute myocarditis after Moderna in young male:\u00a0https://pubmed.ncbi.nlm.nih.gov/34308326/", "https://pubmed.ncbi.nlm.nih.gov/34308326/"], ["", "", "Myocarditis in a healthy male:\u00a0https://pubmed.ncbi.nlm.nih.gov/34229940/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34229940%2F%3Ffbclid%3DIwAR227uKstbxJ8WggxqiKMiB-Jr-sopYy4qt3eGWFBImLSv8K2BCpJQQB824&h=AT27x6peWCRewGmemDzMUfqju5ea49iuGmcZdBxw0HMNUf_TRfm50rjmI-6eYDsxVKCqs9_gyA3tjd3aW_zfwT_pyZWDkFhsuRpvzHfszcgidccMLRj_hHaWKc11_QHjfqeUuOcjLQ3l5SkI2eDRHw&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Acute myocarditis following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34331307/", "https://pubmed.ncbi.nlm.nih.gov/34331307/"], ["", "", "Acute myocarditis following Pfizer in a healthy man with previous COVID infection:\u00a0https://pubmed.ncbi.nlm.nih.gov/34367386/", "https://pubmed.ncbi.nlm.nih.gov/34367386/"], ["", "", "Acute fulminant myocarditis following mRNA vaccination requiring ECMO:\u00a0https://pubmed.ncbi.nlm.nih.gov/34778411/", "https://pubmed.ncbi.nlm.nih.gov/34778411/"], ["", "", "Myocarditis case report:\u00a0https://pubmed.ncbi.nlm.nih.gov/34118375/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34118375%2F%3Ffbclid%3DIwAR2AjVd5qCai3laJnWPVAvjqEndYk2IrUgb_LmL1cDBBoCFzAkfVBj1-kv4&h=AT0wH68dpAaXowlWEUkbaxEnLyLdiQvbtoJ96uodW8VHyIGfXvvcVm399Uz1JU8pIKx1ekAZhixujhcZzjpRG0AaPhMLRoAfMvxDRpEj_zrEPbnLkPTCvzh4aMMdeTHQ9jUXkIEF092ZWYA_HzSUlQ&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Case report: probable myocarditis after mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34712717/", "https://pubmed.ncbi.nlm.nih.gov/34712717/"], ["", "", "Myocarditis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34393273/", "https://pubmed.ncbi.nlm.nih.gov/34393273/"], ["", "", "A late presentation of vaccine induced myocarditis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34660088/", "https://pubmed.ncbi.nlm.nih.gov/34660088/"], ["", "", "Myocarditis in 24yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34268277/", "https://pubmed.ncbi.nlm.nih.gov/34268277/"], ["", "", "Myocarditis in a 24yoM nurse after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34400043/", "https://pubmed.ncbi.nlm.nih.gov/34400043/"], ["", "", "Myocarditis in a 15yo following Pfizer:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369878/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369878/"], ["", "", "Myopericarditis in a 16yo following vaccination", "Myopericarditis in a 16yo following vaccination:"], ["", "", "Myocarditis in a 16yo, late gadolinium enhancement:\u00a0https://pubmed.ncbi.nlm.nih.gov/34778788/", "https://pubmed.ncbi.nlm.nih.gov/34778788/"], ["", "", "Myocarditis in a 22yoM following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34348657/", "https://pubmed.ncbi.nlm.nih.gov/34348657/"], ["", "", "Myocarditis in a 18yoM following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804729/", "https://pubmed.ncbi.nlm.nih.gov/34804729/"], ["", "", "Myocarditis in a middle aged male with significant left ventricular dysfunction following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34795198/", "https://pubmed.ncbi.nlm.nih.gov/34795198/"], ["", "", "70yoF with myocarditis following J&J Vaccination:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270733/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270733/"], ["", "", "Biopsy proven lymphocytic myocarditis following 1st\u00a0mRNA vaccination in a 40yo:\u00a0https://pubmed.ncbi.nlm.nih.gov/34487236/", "https://pubmed.ncbi.nlm.nih.gov/34487236/"], ["", "", "Cardiac imaging of acute myocarditis following mRNA in a 24yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34402228/", "https://pubmed.ncbi.nlm.nih.gov/34402228/"], ["", "", "Cardiac MRI findings in young adults following mRNA vaccination: a case series:\u00a0https://pubmed.ncbi.nlm.nih.gov/34496880/", "https://pubmed.ncbi.nlm.nih.gov/34496880/"], ["", "", "Cardiac complications following mRNA vaccination: a systematic review of case reports and case series:https://pubmed.ncbi.nlm.nih.gov/34921468/"], ["", "", "Myopericarditis following mRNA vaccination: the role of cardiac biomarkers and multimodality imaging:\u00a0https://pubmed.ncbi.nlm.nih.gov/34487161/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34487161/"], ["", "", "Myocarditis should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34463755/", "https://pubmed.ncbi.nlm.nih.gov/34463755/"], ["", "", "Myocarditis Associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings:\u00a0https://pubmed.ncbi.nlm.nih.gov/34428917/", "https://pubmed.ncbi.nlm.nih.gov/34428917/"], ["", "", "Cardiac magnetic resonance characteristics of acute myocarditis occuring after mRNA vaccine immunization:\u00a0https://pubmed.ncbi.nlm.nih.gov/34787887/", "https://pubmed.ncbi.nlm.nih.gov/34787887/"], ["", "", "Fulminant myocarditis and systemic hyperinflammation in 2 patients following mRNA:\u00a0https://pubmed.ncbi.nlm.nih.gov/34416319/", "https://pubmed.ncbi.nlm.nih.gov/34416319/"], ["", "", "2 cases of histological confirmed myocarditis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34407340/", "https://pubmed.ncbi.nlm.nih.gov/34407340/"], ["", "", "Myocarditis and Pericarditis: 2 case reports:\u00a0https://pubmed.ncbi.nlm.nih.gov/34277198/", "https://pubmed.ncbi.nlm.nih.gov/34277198/"], ["", "", "Two cases of myocarditis", "Two cases of myocarditis:"], ["", "", "3 cases of cardiac manifestation following Pfizer:\u00a0https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab177/6311674", "https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab177/6311674"], ["", "", "4 cases of Myocarditis and their Cardiac MRI findings:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245050/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245050/"], ["", "", "4 cases of myocarditis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34396358/", "https://pubmed.ncbi.nlm.nih.gov/34396358/"], ["", "", "6 cases of men age 17-37 with myocarditis:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219373/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219373/"], ["", "", "8 cases of myocarditis in adolescents following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34319393/", "https://pubmed.ncbi.nlm.nih.gov/34319393/"], ["", "", "13 cases of Myocarditis in adolescents following Pfizer:\u00a0https://www.jpeds.com/article/S0022-3476(21)00665-X/fulltext", "https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.jpeds.com%2Farticle%2FS0022-3476(21)00665-X%2Ffulltext%3Ffbclid%3DIwAR3Wonw68HnwR-Ht3I5a8PX-KrZtIs-VJ9_Q2UHu9iNttl3Q_6ohrDifzBg&h=AT0xWzijkyUeVUGuBHkrqd3CSSbTQhC7AP5JvVCmmxCveNNsTY-d8h5QbPKFwmowH7EwXAMwT2pzcQSONhZeO4OYeqeR0Gz9UFAjJhl9MZJwaJK8q25a8V453JAw4DOFW_hK5wfQ_4L3azBH0YA7og&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Review of 15 published cases of myocarditis:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272967/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272967/"], ["", "", "Myocarditis and pericarditis due to mRNA vaccines in 19 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/34805376/", "https://pubmed.ncbi.nlm.nih.gov/34805376/"], ["", "", "Myocarditis in 23 military members:\u00a0https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601"], ["", "", "Review of 29 published cases of acute myopericarditis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34356586/", "https://pubmed.ncbi.nlm.nih.gov/34356586/"], ["", "", "Review of 214 myocarditis cases::\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233865/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233865/"], ["", "", "Cardiomyopathy:"], ["", "", "Covid-19 vaccine associated Takotsubo cardiomyopathy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34375049/", "https://pubmed.ncbi.nlm.nih.gov/34375049/"], ["", "", "63yoF with Takotsubo cardiomyopathy following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34330629/", "https://pubmed.ncbi.nlm.nih.gov/34330629/"], ["", "", "Reverse takotsubo\u00a0cardiomyopathy as a cause of acute chest pain in a young woman following COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34961327/", "https://pubmed.ncbi.nlm.nih.gov/34961327/"], ["", "", "Acute MI:"], ["", "", "3 cases of acute infarct-like myocarditis (2 Pfizer, 1 AstraZeneca):\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325525/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325525/"], ["", "", "2 cases of acute MI <24 hours after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34364657/", "https://pubmed.ncbi.nlm.nih.gov/34364657/"], ["", "", "Acute STEMI MI following AstraZeneca vaccination,?Kounis syndrome?:\u00a0\u00a0https://pubmed.ncbi.nlm.nih.gov/34394944/", "https://pubmed.ncbi.nlm.nih.gov/34394944/"], ["", "", "Vaccine induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34486030/", "https://pubmed.ncbi.nlm.nih.gov/34486030/"], ["", "", "Hypertension:"], ["", "", "Hypertension following mRNA vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206586/        Hypertension following mRNA vaccination:                                                                                                                                                                                                ", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206586/"], ["", "", "POTS:"], ["", "", "POTS following Pfizer:\u00a0https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine", "https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine"], ["", "", "Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine "], ["", "", "Tachycardia:"], ["", "", "Isolated tachycardia in a 29yoF following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34466331/", "https://pubmed.ncbi.nlm.nih.gov/34466331/"], ["", "", "Tachycardia following Pfizer: 3 cases in those previously infected with COVID-19:https://pubmed.ncbi.nlm.nih.gov/33858709/", "https://pubmed.ncbi.nlm.nih.gov/33858709/"], ["", "", "Long QT / Conduction Disturbance:"], ["", "", "VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34791122/", "https://pubmed.ncbi.nlm.nih.gov/34791122/"], ["", "", "Long QT syndrome following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804335/", "https://pubmed.ncbi.nlm.nih.gov/34804335/"], ["", "", "Two cases of vaccine induced cardiac conduction disturbance following Pfizer and AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34796078/", "https://pubmed.ncbi.nlm.nih.gov/34796078/"], ["", "", "Dizziness, HTN and new LBBB following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34508485/", "https://pubmed.ncbi.nlm.nih.gov/34508485/"], ["", "", "Frequent PVS and NSVT following 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34275963/", "https://pubmed.ncbi.nlm.nih.gov/34275963/"], ["", "", "Other:"], ["", "", "Posttransplant lymphoproliferative disorder after AstraZeneca in a heart transplant recipient:\u00a0https://pubmed.ncbi.nlm.nih.gov/34702598/", "https://pubmed.ncbi.nlm.nih.gov/34702598/"], [], ["", "", "GI:", "GI:"], ["", "", "Risk of adverse events and reported relapse after COVID-19 vaccination in patients with IBD:\u00a0https://pubmed.ncbi.nlm.nih.gov/34819330/", "https://pubmed.ncbi.nlm.nih.gov/34819330/"], ["", "", "Gastroparesis:"], ["", "", "Gastroparesis following Pfizer:\u00a0https://journals.lww.com/ajg/Citation/9900/Gastroparesis_After_Pfizer_BioNTech_COVID_19.28.aspx", "https://journals.lww.com/ajg/Citation/9900/Gastroparesis_After_Pfizer_BioNTech_COVID_19.28.aspx"], ["", "", "Pancreas:"], ["", "", "14yoF with acute pancreatitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35081801/", "https://pubmed.ncbi.nlm.nih.gov/35081801/"], ["", "", "17yoM with acute pancreatitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35053654/", "https://pubmed.ncbi.nlm.nih.gov/35053654/"], ["", "", "71yoF with acute pancreatitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35029194/", "https://pubmed.ncbi.nlm.nih.gov/35029194/"], ["", "", "Pancreatitis injury after Pfizer, a case report: https://pubmed.ncbi.nlm.nih.gov/34205898/", "https://pubmed.ncbi.nlm.nih.gov/34205898/"], ["", "", "Acute Necrotizing Pancreatitis following 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34423463/", "https://pubmed.ncbi.nlm.nih.gov/34423463/"], ["", "", "Acute Pancreatitis in a 96yoF following 1st\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34084669/", "https://pubmed.ncbi.nlm.nih.gov/34084669/?fbclid=IwAR0ZEVWMJWhR4Tu0_yvWz0Oe8sIDGU3e-9S1ZiUT9cvRgzOUiIk_oSvbc0E"], ["", "", "Pancreas allograft rejection following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34781027/", "https://pubmed.ncbi.nlm.nih.gov/34781027/"], ["", "", "Hepatitis :"], ["", "", "Cutaneous hypersensitivity reaction with acute hepatitis following Pfizer 2nd\u00a0dose:\u00a0https://pubmed.ncbi.nlm.nih.gov/34485657/", "https://pubmed.ncbi.nlm.nih.gov/34485657/"], ["", "", "35yoF third month post partum with autoimmune hepatitis following vaccination: https://pubmed.ncbi.nlm.nih.gov/33862041/", "https://pubmed.ncbi.nlm.nih.gov/33862041/"], ["", "", "Liver transplant in a 53yo healthy man due to vaccine induced autoimmune hepatitis and subsequent liver failure following Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/35175635/"], ["", "", "65yoM with autoimmune hepatitis following Moderna: https://pubmed.ncbi.nlm.nih.gov/34717185/", "https://pubmed.ncbi.nlm.nih.gov/34717185/"], ["", "", "79yoM with AstraZeneca induced autoimmune hepatitis: https://pubmed.ncbi.nlm.nih.gov/35013724/", "https://pubmed.ncbi.nlm.nih.gov/35013724/"], ["", "", "Three cases of autoimmune hepatitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34904265/", "https://pubmed.ncbi.nlm.nih.gov/34904265/"], ["", "", "A case of hepatotoxicity in 14yoF after receiving Pfizer vaccine: https://pubmed.ncbi.nlm.nih.gov/35070524/", "https://pubmed.ncbi.nlm.nih.gov/35070524/"], ["", "", "AMA-positive hepatitis in a 56yoF induced by Pfizer vaccine: https://pubmed.ncbi.nlm.nih.gov/35040333/"], ["", "", "Hepatic artery occlusion following Astrazeneca: https://pubmed.ncbi.nlm.nih.gov/34926142/"], ["", "", "Acute cholestatic hepatitis after Pfizer vaccine: https://pubmed.ncbi.nlm.nih.gov/34256064/"], ["", "", "52yoF with autoimmune hepatitis following Moderna: https://onlinelibrary.wiley.com/doi/10.1111/liv.15092"], ["", "", "41yo F with Autoimmune hepatitis following Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197609/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197609/"], ["", "", "76yoF with autoimmune hepatitis following Moderna Vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34332438/", "https://pubmed.ncbi.nlm.nih.gov/34332438/"], ["", "", "71yoF with Autoimmune hepatitis after mRNA vaccine (Moderna)", "71yoF with Autoimmune hepatitis after mRNA vaccine (Moderna):"], ["", "", "80yoF with autoimmune hepatitis following Pfizer:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186938/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186938/"], ["", "", "63yoM with autoimmune hepatitis following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34293683/", "https://pubmed.ncbi.nlm.nih.gov/34293683/"], ["", "", "61yoF with liver injury following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34430106/", "https://pubmed.ncbi.nlm.nih.gov/34430106/"], ["", "", "61yoF with autoimmune hepatitis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34781161/", "https://pubmed.ncbi.nlm.nih.gov/34781161/"], ["", "", "35yoF with autoimmune hepatitis following Pfizer:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056822/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056822/"], ["", "", "New Onset autoimmune hepatitis following mRNA vaccination in a 36yoF with Primary sclerosing cholangitis:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384483/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384483/"], ["", "", "56yoF with autoimmune hepatitis following Moderna:\u00a0https://www.journal-of-hepatology.eu/article/S0168-8278(21)00424-4/fulltext", "https://www.journal-of-hepatology.eu/article/S0168-8278(21)00424-4/fulltext"], ["", "", "Two cases of autoimmune hepatitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34225251/", "https://pubmed.ncbi.nlm.nih.gov/34225251/"], ["", "", "Liver injury in a liver transplant patient following mRNA vaccination:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214934/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214934/?fbclid=IwAR3uqF7B4c6Ds7FhQm7UqXK6az47wy9tGyWN8fzXDMo38927mAi1OAGOn1U"], ["", "", "16 cases of liver injury following Pfizer and Moderna: a multicenter case series:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324396/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324396/"], ["", "", "Reactivation of Hepatitis C infection following Pfizer in a 82yoF:\u00a0https://www.dovepress.com/hepatitis-c-virus-reactivation-following-covid-19-vaccination--a-case--peer-reviewed-fulltext-article-IMCRJ?fbclid=IwAR3u0x1baFcAZz1eOrNsXsgmrlUYt0EJV2SmoXA75RiplFQbPrtSAIo2GAs", "https://www.dovepress.com/hepatitis-c-virus-reactivation-following-covid-19-vaccination--a-case--peer-reviewed-fulltext-article-IMCRJ?fbclid=IwAR3u0x1baFcAZz1eOrNsXsgmrlUYt0EJV2SmoXA75RiplFQbPrtSAIo2GAs"], ["", "", "Other:"], ["", "", "Inflammatory Bowel Disease triggered by Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34922342/"], ["", "", "Sclerosing Cholangitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34450237/", "https://pubmed.ncbi.nlm.nih.gov/34450237/"], ["", "", "Unusual fever, HA, and abdominal pain in a healthy woman following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34339677/", "https://pubmed.ncbi.nlm.nih.gov/34339677/"], ["", "", "Hepatic vein thrombosis due to TTS following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34432063/", "https://pubmed.ncbi.nlm.nih.gov/34432063/"], ["", "", "3 cases of portal vein thrombosis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34776709/", "https://pubmed.ncbi.nlm.nih.gov/34776709/"], [], ["", "", "Renal:", "Renal:"], ["", "", "ANCA:"], ["", "", "ANCA glomerulonephritis after Moderna:\u00a0https://www.kidney-international.org/article/S0085-2538(21)00555-X/fulltext", "https://www.kidney-international.org/article/S0085-2538(21)00555-X/fulltext"], ["", "", "Case report: ANCA vasculitis with acute renal failure and pulmonary hemorrhage after Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34859017/", "https://pubmed.ncbi.nlm.nih.gov/34859017/"], ["", "", "New onset ANCA vasculitis after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34280507/", "https://pubmed.ncbi.nlm.nih.gov/34280507/"], ["", "", "ANCA associated Glomerulonephritis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34423176/", "https://pubmed.ncbi.nlm.nih.gov/34423176/"], ["", "", "ANCA associated\u00a0vasculitis presenting with Rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34659268/", "https://pubmed.ncbi.nlm.nih.gov/34659268/"], ["", "", "PTU-induced ANCA-associated vasculitis after Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34451967/", "https://pubmed.ncbi.nlm.nih.gov/34451967/"], ["", "", "Relapsed ANCA associated\u00a0vasculitis following AstraZeneca: A case series of two patients:\u00a0https://pubmed.ncbi.nlm.nih.gov/34755433/", "https://pubmed.ncbi.nlm.nih.gov/34755433/"], ["", "", "ANCA associated vasculitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34416184/", "https://pubmed.ncbi.nlm.nih.gov/34416184/"], ["", "", "Nephrotic Syndrome:"], ["", "", "Nephrotic Syndrome following AstraZeneca:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257404/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257404/"], ["", "", "New onset pediatric nephrotic syndrome following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34782983/", "https://pubmed.ncbi.nlm.nih.gov/34782983/"], ["", "", "Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca:\u00a0https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab215/6318785", "https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab215/6318785"], ["", "", "Minimal Change Disease:"], ["", "", "MCD relapse following Pfizer in a man in his mid-60s:\u00a0https://pubmed.ncbi.nlm.nih.gov/34023417/", "https://pubmed.ncbi.nlm.nih.gov/34023417/"], ["", "", "MCD relapse following Pfizer in a 34yoF:\u00a0https://pubmed.ncbi.nlm.nih.gov/33964312/", "https://pubmed.ncbi.nlm.nih.gov/33964312/"], ["", "", "Severe Minimal change disease relapse 3 days following Pfizer:\u00a0https://europepmc.org/article/pmc/pmc8156905", "https://europepmc.org/article/pmc/pmc8156905"], ["", "", "Minimal Change Disease with nephrotic syndrome and AKI following Pfizer in a 50yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/33839200/", "https://pubmed.ncbi.nlm.nih.gov/33839200/"], ["", "", "Minimal change disease in 80\u2019s yoM following first dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33992727/", "https://pubmed.ncbi.nlm.nih.gov/33992727/"], ["", "", "Minimal change disease after 1st\u00a0dose Pfizer 60yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804557/", "https://pubmed.ncbi.nlm.nih.gov/34804557/"], ["", "", "Minimal change disease and AKI in a 77yoM following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34000278/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34000278/"], ["", "", "Minimal change disease 4 days after Pfizer in a 45yoF:\u00a0https://pubmed.ncbi.nlm.nih.gov/34721864/", "https://pubmed.ncbi.nlm.nih.gov/34721864/"], ["", "", "Minimal change disease in a 39yo after 1st\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34143368/", "https://pubmed.ncbi.nlm.nih.gov/34143368/"], ["", "", "Minimal Change disease in a 63yoF following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34048824/", "https://pubmed.ncbi.nlm.nih.gov/34048824/"], ["", "", "Minimal change disease in a 43yoM following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34052236/", "https://pubmed.ncbi.nlm.nih.gov/34052236/"], ["", "", "Relapse of minimal change disease with severe nephrotic syndrome in a 22yoM following Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156905/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156905/"], ["", "", "Minimal Change disease and Severe AKI following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34242687/", "https://pubmed.ncbi.nlm.nih.gov/34242687/"], ["", "", "Relapse of Minimal Change disease in a 30yoM following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34119512/", "https://pubmed.ncbi.nlm.nih.gov/34119512/"], ["", "", "New onset Nephrotic syndrome due to Minimal Change disease following J&J:\u00a0https://pubmed.ncbi.nlm.nih.gov/34342187/", "https://pubmed.ncbi.nlm.nih.gov/34342187/"], ["", "", "2 cases of minimal change disease following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34779088/", "https://pubmed.ncbi.nlm.nih.gov/34779088/"], ["", "", "3 cases of minimal change disease following 2nd\u00a0dose of mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34337193/", "https://pubmed.ncbi.nlm.nih.gov/34337193/"], ["", "", "13 cases of new or relapsing minima change disease following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34632166/", "https://pubmed.ncbi.nlm.nih.gov/34632166/"], ["", "", "Nephropathy / IGA Vasculitis:"], ["", "", "Acute interstitial nephritis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35113012/"], ["", "", "A case of acute interstitial nephritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34219853/"], ["", "", "Acute interstitial nephritis in a 45yoF following 2 doses of Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650829/"], ["", "", "Isolated renal arteritis with infarction after Pfizer COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35095058/"], ["", "", "13 cases of new or relapsed glomerulonephritis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34632166/"], ["", "", "48 cases of new onset and relapsed kidney histopathology following COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622870/"], ["", "", "New onset of Class III lupus nephritis with multi-organ involvement after Pfizer: https://pubmed.ncbi.nlm.nih.gov/35108572/"], ["", "", "IgA nephropathy presenting as rapidly progressive glomerulonephritis in a 13yo following 1st\u00a0dose of Pfizer", "IgA nephropathy presenting as rapidly progressive glomerulonephritis in a 13yo following 1st\u00a0dose of Pfizer:]https://pubmed.ncbi.nlm.nih.gov/34786589/\u00a0\u00a0"], ["", "", "IgA and crescentic glomerulonephritis following Pfizer", "IgA and crescentic glomerulonephritis following Pfizer:"], ["", "", "17yoM with newly diagnosed IgA nephropathy with gross hematuria following Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34865167/"], ["", "", "17yoF with IgA nephropathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35118635/"], ["", "", "IgA nephropathy in a 28yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35110484/"], ["", "", "28yoF with flare up of IgA nephropathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35108771/"], ["", "", "29yoF with hematuria and likely IgA nephritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35102819/"], ["", "", "IgA nephropathy flare up following Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079938/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079938/"], ["", "", "IgA Nephropathy after mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34278290/", "https://pubmed.ncbi.nlm.nih.gov/34278290/"], ["", "", "IgA nephropathy flare-up following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34415336/", "https://pubmed.ncbi.nlm.nih.gov/34415336/"], ["", "", "IgA nephropathy following vaccination in a renal transplant recipient with a history of aristolochic acid nephropathy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34816609/", "https://pubmed.ncbi.nlm.nih.gov/34816609/"], ["", "", "IgA nephropathy in 2 pediatric patients after Pfizer (13 and 17yo):\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/"], ["", "", "3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166778/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166778/"], ["", "", "2 cases of IgA nephropathy patients developing exacerbations following moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987498/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987498/"], ["", "", "2 cases of IgA Nephropathy patients developing hematuria after Pfizer:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329426/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329426/"], ["", "", "Reactivation of IgA vasculitis following Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260100/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260100/"], ["", "", "Reactivation of IgA\u00a0vasculitis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34848431/", "https://pubmed.ncbi.nlm.nih.gov/34848431/"], ["", "", "Case of IgA\u00a0vasculitis following Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34535924/", "https://pubmed.ncbi.nlm.nih.gov/34535924/"], ["", "", "IgA vasculitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34509658/", "https://pubmed.ncbi.nlm.nih.gov/34509658/"], ["", "", "IgA vasculitis with renal and skin involvement following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34779011/", "https://pubmed.ncbi.nlm.nih.gov/34779011/"], ["", "", "Membranous nephropathy following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34419553/", "https://pubmed.ncbi.nlm.nih.gov/34419553/"], ["", "", "Membranous nephropathy following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34332960/", "https://pubmed.ncbi.nlm.nih.gov/34332960/"], ["", "", "Other:"], ["", "", "Gross hematuria after mRNA vaccination in two patients with histological and clinical diagnosis of IgA nephropathy: https://pubmed.ncbi.nlm.nih.gov/34766415/"], ["", "", "Gross hematuria after Moderna vaccination for COVID in 2 patients with IgA nephropathy:https://pubmed.ncbi.nlm.nih.gov/33771584/"], ["", "", "Distinct glomerular disease after mRNA vaccination: A Vigibase analysis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34822875/", "https://pubmed.ncbi.nlm.nih.gov/34822875/"], ["", "", "Renal Thrombotic Microangiopathy following Pfizer in a 35yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34451509/", "https://pubmed.ncbi.nlm.nih.gov/34451509/"], ["", "", "Glomerulopathies after vaccination against covid-19: four cases with three different vaccines in Argentina:\u00a0https://pubmed.ncbi.nlm.nih.gov/34728874/", "https://pubmed.ncbi.nlm.nih.gov/34728874/"], [], ["", "", "Rheumatology/Endocrinology/Orthopedics", "Rheumatology/Endocrinology/Orthopedics:"], ["", "", "General:"], ["", "", "Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still\u2019s disease", "Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still\u2019s disease:\u00a0"], ["", "", "Immune mediated disease flares:\u00a0https://pubmed.ncbi.nlm.nih.gov/33946748/", "https://pubmed.ncbi.nlm.nih.gov/33946748/"], ["", "", "Local and systemic reactogenicity of Pfizer in patients with systemic lupus and rheumatoid arthritis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34476603/", "https://pubmed.ncbi.nlm.nih.gov/34476603/"], ["", "", "Incidence of disease flare after Pfizer vaccination in patients with rheumatoid arthritis in remission:\u00a0https://pubmed.ncbi.nlm.nih.gov/34472714/", "https://pubmed.ncbi.nlm.nih.gov/34472714/"], ["", "", "11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34346185/", "https://pubmed.ncbi.nlm.nih.gov/34346185/"], [], ["", "", "Macrophage Activation Syndrome:"], ["", "", "Macrophage activation syndrome in a patient with adult-onset Still\u2019s disease following first dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34961551/", "https://pubmed.ncbi.nlm.nih.gov/34961551/"], ["", "", "Still's Disease:"], ["", "", "Adult onset Still\u2019s disease following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34316728/", "https://pubmed.ncbi.nlm.nih.gov/34316728/"], ["", "", "Adult onset Still\u2019s disease after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35186544/"], ["", "", "Flare up of adult onset Still\u2019s disease in a 37yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34622765/"], ["", "", "Adult onset Still\u2019s disease in a 43yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34763089/"], ["", "", "Flare of adult onset still\u2019s disease following Pfizer in a 49yoF: https://pubmed.ncbi.nlm.nih.gov/35182269/"], ["", "", "Still\u2019s disease in a 34yoF following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34797392/", "https://pubmed.ncbi.nlm.nih.gov/34797392/"], ["", "", "Adult onset Still\u2019s\u00a0disease in a 36yo following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34962116/", "https://pubmed.ncbi.nlm.nih.gov/34962116/"], ["", "", "Adult onset Still\u2019s disease following mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34316726/", "https://pubmed.ncbi.nlm.nih.gov/34316726/"], ["", "", "Lupus:"], ["", "", "New onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34560139/"], ["", "", "Lupus nephritis flare following Moderna: https://pubmed.ncbi.nlm.nih.gov/34791449/"], ["", "", "Lupus exacerbation:\u00a0https://onlinelibrary.wiley.com/doi/10.1111/dth.15017", "https://l.facebook.com/l.php?u=https%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fdth.15017%3Ffbclid%3DIwAR33E9FNK_lTLQxBw9Aau9XA6P0ldarls0xIYslZND6Wv_-3wgqqRY2mdrw&h=AT10SXRvZOpLkwiOqddyGvOhRoRRbM1d0dXnnoyKok5-DLMNHOF3CkKKXtyhBWBP2gkFAN0I7yO6CGAb0yNUwZD6pcDtduoAuxch9_p6hw59TxJTWQJYbJrxTn21Oe9MdktufiQj6bZ0T-ppadpuRA&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Lupus exacerbation following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34291477/", "https://pubmed.ncbi.nlm.nih.gov/34291477/"], ["", "", "27 cases of lupus flare following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34782941/", "https://pubmed.ncbi.nlm.nih.gov/34782941/"], ["", "", "New onset lupus following mRNA vaccination in a 27yoF: https://pubmed.ncbi.nlm.nih.gov/35186342/"], ["", "", "Systemic lupus following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34418261/", "https://pubmed.ncbi.nlm.nih.gov/34418261/"], ["", "", "Relapse of class V lupus. Nephritis after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34352310/", "https://pubmed.ncbi.nlm.nih.gov/34352310/"], ["", "", "Subacute cutaneous lupus erythematosus flare triggered by Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34455671/", "https://pubmed.ncbi.nlm.nih.gov/34455671/"], ["", "", "Subacute cutaneous lupus erythematous after Pfizer in a woman with primary biliary cholangitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34807495/", "https://pubmed.ncbi.nlm.nih.gov/34807495/"], ["", "", "Emergence of new onset SLE following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34450645/", "https://pubmed.ncbi.nlm.nih.gov/34450645/"], ["", "", "Hyperglycemic / Glucose:"], ["", "", "COVID-19 vaccine and hyperosmolar hyperglycemic state: https://pubmed.ncbi.nlm.nih.gov/33927933/"], ["", "", "Acute Hyperglycemic crisis: a case series of 3 patients following AstraZeneca:\u00a0https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.14631", "https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.14631?fbclid=IwAR0zNM7kR-qFwu9U8O56UeqsD0ix4IvBOqG4kzeKgDM-4X3EWGHZdvwN4TM"], ["", "", "Newly developed type 1 diabetes after Moderna in a 73yoF: https://pubmed.ncbi.nlm.nih.gov/35088548/"], ["", "", "3 cases of exacerbation of hyperglycemia in patients with type 2 diabetes following AstraZeneca:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143905/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143905/"], ["", "", "3 cases of hyperglycemic emergencies following Pfizer and Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34604689/", "https://pubmed.ncbi.nlm.nih.gov/34604689/"], ["", "", "Perturbation of blood glucose following vaccination, a review of 20 adults:\u00a0\u00a0https://pubmed.ncbi.nlm.nih.gov/34375490/", "https://pubmed.ncbi.nlm.nih.gov/34375490/"], ["", "", "Hypertriglyceridemia following Pfizer vaccination in a patient with familial hypercholesteremia: https://pubmed.ncbi.nlm.nih.gov/34533798/"], ["", "", "Thyroid:"], ["", "", "Silent thyroiditis following Pfizer, subacute thyroiditis following moderna, and Graves disease following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34792795/", "https://pubmed.ncbi.nlm.nih.gov/34792795/"], ["", "", "Subacute thyroiditis after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35095149/"], ["", "", "SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review: https://pubmed.ncbi.nlm.nih.gov/35094372/"], ["", "", "11 cases of COVID-19 vaccine induced subacute thyroiditis: https://pubmed.ncbi.nlm.nih.gov/35182366/"], ["", "", "Subacute Thyroiditis:\u00a0https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1947102?fbclid=IwAR02FYW94iQGbu6e2uTpD42XoIwp6QHzwhDBWotULtT4ZCGR5sVKkyexbRg", "https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1947102?fbclid=IwAR02FYW94iQGbu6e2uTpD42XoIwp6QHzwhDBWotULtT4ZCGR5sVKkyexbRg"], ["", "", "Subacute thyroiditis following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34690055/", "https://pubmed.ncbi.nlm.nih.gov/34690055/"], ["", "", "Subacute thyroiditis following Moderna vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34777881/", "https://pubmed.ncbi.nlm.nih.gov/34777881/"], ["", "", "Subacute thyroiditis following Pfizer: a tale of two sisters:\u00a0https://pubmed.ncbi.nlm.nih.gov/34686971/", "https://pubmed.ncbi.nlm.nih.gov/34686971/"], ["", "", "42yoF with subacute thyroiditis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34907904/"], ["", "", "Thyroiditis after mRNA vaccine: a case series: https://pubmed.ncbi.nlm.nih.gov/34934810/"], ["", "", "Two cases of subacute thyroiditis after Moderna and AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34504856/", "https://pubmed.ncbi.nlm.nih.gov/34504856/"], ["", "", "4 cases of subacute thyroiditis after Pfizer vaccine: https://pubmed.ncbi.nlm.nih.gov/34893014/"], ["", "", "Two cases of thyroiditis after Pfizer and AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34693241/", "https://pubmed.ncbi.nlm.nih.gov/34693241/"], ["", "", "New onset Graves disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34888290/"], ["", "", "Graves disease following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34969799/"], ["", "", "Graves disease following mRNA COVID-19 vaccination: case series: https://pubmed.ncbi.nlm.nih.gov/34939881/"], ["", "", "New onset Graves disease and autoimmune diabetes mellitus following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34653776/", "https://pubmed.ncbi.nlm.nih.gov/34653776/"], ["", "", "Two cases of Graves disease following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33858208/", "https://pubmed.ncbi.nlm.nih.gov/33858208/"], ["", "", "Two more cases of Graves disease following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34342859/", "https://pubmed.ncbi.nlm.nih.gov/34342859/"], ["", "", "Hyperthyroidism following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34696214/", "https://pubmed.ncbi.nlm.nih.gov/34696214/"], ["", "", "Adrenal:"], ["", "", "5 cases of adrenal crisis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34358373/", "https://pubmed.ncbi.nlm.nih.gov/34358373/"], ["", "", "Myositis in a 56yoF following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33647971/", "https://pubmed.ncbi.nlm.nih.gov/33647971/"], ["", "", "COVID-19 vaccine induced cellulitis and myositis: https://pubmed.ncbi.nlm.nih.gov/34857596/"], ["", "", "New onset giant cell arteritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35112193/"], ["", "", "2 cases of\u00a0L\u00f6fgren's syndrome following AstraZeneca and Moderna vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34835244/", "https://pubmed.ncbi.nlm.nih.gov/34835244/"], ["", "", "mRNA induced rhabdomyolysis and fasciitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34435250/", "https://pubmed.ncbi.nlm.nih.gov/34435250/"], ["", "", "Rhabdomyolysis after Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34150372/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34150372%2F%3Ffbclid%3DIwAR2AjVd5qCai3laJnWPVAvjqEndYk2IrUgb_LmL1cDBBoCFzAkfVBj1-kv4&h=AT12QI6YulZudIaJpjBSKy966MO22CwLNq8NLntHXgXmojtZFgz0gzrHrmlKMF2UxDxIYbzx1fDrb0-NJIaAA60NwQCLDIagur3YB_ZoqoPgn-K2jnZaw_smJBt_nFRCy5FQGCPxJOsoV1wQHPTqnQ&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "21yoM with Pfizer induced rhabdomyolysis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34186348/", "https://pubmed.ncbi.nlm.nih.gov/34186348/"], ["", "", "Inflammation / Arthritis:"], ["", "", "Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases: https://pubmed.ncbi.nlm.nih.gov/34836886/"], ["", "", "Quadrilateral space region inflammation and other incidental findings on shoulder MRI following Pfizer COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34306275/", "https://pubmed.ncbi.nlm.nih.gov/34306275/"], ["", "", "Rash, arthritis, swelling, muscle weakness following AstraZeneca:\u00a0https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175", "https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175?fbclid=IwAR1J0lPNmupRhj7K8GZjwRg5pd5en_jWffhr1CJSvgXKq3aOZxvSR4lbbIk"], ["", "", "Self-limiting polymyalgia rheumatic-like syndrome following Moderna vaccination: https://pubmed.ncbi.nlm.nih.gov/34980802/"], ["", "", "Polyarthralgia and Myalgia syndrome after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34463066/", "https://pubmed.ncbi.nlm.nih.gov/34463066/"], ["", "", "Severe polyarthralgia in elderly female following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34835151/", "https://pubmed.ncbi.nlm.nih.gov/34835151/"], ["", "", "Arthritis in the L elbow following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34363344/", "https://pubmed.ncbi.nlm.nih.gov/34363344/"], ["", "", "Vasculitis and bursitis on 18F FDG-PET/CT following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34495381/", "https://pubmed.ncbi.nlm.nih.gov/34495381/"], ["", "", "Remitting seronegative symmetrical synovitis with pitting edema following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34348912/", "https://pubmed.ncbi.nlm.nih.gov/34348912/"], ["", "", "COVID-19 vaccination and large0vessel giant cell arteritis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34788208/", "https://pubmed.ncbi.nlm.nih.gov/34788208/"], ["", "", "HSP:"], ["", "", "40yoF with Henoch-Schonlein Purpura (HSP) following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34247902/", "https://pubmed.ncbi.nlm.nih.gov/34247902/"], ["", "", "45yoF with reactivation of HSP following Pfizer booster:\u00a0https://pubmed.ncbi.nlm.nih.gov/34745629/", "https://pubmed.ncbi.nlm.nih.gov/34745629/"], ["", "", "62yo with HSP following\u00a0AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34518812/", "https://pubmed.ncbi.nlm.nih.gov/34518812/"], ["", "", "76yoF with\u00a0HSP following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34696186/", "https://pubmed.ncbi.nlm.nih.gov/34696186/"], ["", "", "Psoriasis:"], ["", "", "New onset mainly guttate psoriasis after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34309932/", "https://pubmed.ncbi.nlm.nih.gov/34309932/"], ["", "", "2 cases of exacerbation of plaque psoriasis after Pfizer and CoronaVac:\u00a0https://pubmed.ncbi.nlm.nih.gov/34427024/", "https://pubmed.ncbi.nlm.nih.gov/34427024/"], ["", "", "Psoriatic spondyloarthritis exacerbation triggered by mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/35176180/"], ["", "", "14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca):\u00a0https://pubmed.ncbi.nlm.nih.gov/34363647/", "https://pubmed.ncbi.nlm.nih.gov/34363647/"], ["", "", "Pustuluar psoriasis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34398977/", "https://pubmed.ncbi.nlm.nih.gov/34398977/"], ["", "", "Psorasis exacerbation after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34487570/", "https://pubmed.ncbi.nlm.nih.gov/34487570/"], ["", "", "Scleroderma renal crisis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34339745/", "https://pubmed.ncbi.nlm.nih.gov/34339745/"], ["", "", "Cryoglobulinaemia:"], ["", "", "Flares of mixed cryoglobulineamia vasculitis after vaccination", "https://pubmed.ncbi.nlm.nih.gov/34819272/"], ["", "", "Pheochromocytoma crisis following J&J vaccination: https://pubmed.ncbi.nlm.nih.gov/34707965/"], [], ["", "", "Hematology", "Hematology"], ["", "", "Treatment Guide to Thrombotic Thrombocytopenia Following Vaccination:\u00a0https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia", "https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia"], ["", "", "Successful venous thromboprophylaxis in a patient with AstraZeneca induced VITT:\u00a0https://pubmed.ncbi.nlm.nih.gov/34496889/", "https://pubmed.ncbi.nlm.nih.gov/34496889/"], ["", "", "Autoimmunity roots of the thrombotic events following COVID vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34508917/", "https://pubmed.ncbi.nlm.nih.gov/34508917/"], ["", "", "Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways:\u00a0https://pubmed.ncbi.nlm.nih.gov/34479129/", "https://pubmed.ncbi.nlm.nih.gov/34479129/"], ["", "", "Changes in blood\u00a0viscosity after COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34868465/", "https://pubmed.ncbi.nlm.nih.gov/34868465/"], ["", "", "Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34474550/", "https://pubmed.ncbi.nlm.nih.gov/34474550/"], ["", "", "The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopenia:https://pubmed.ncbi.nlm.nih.gov/34472568/", "https://pubmed.ncbi.nlm.nih.gov/34472568/"], ["", "", "Life-changing\u00a0consequences of vaccine-induced immune-mediated thrombosis with thrombocytopenia:\u00a0https://pubmed.ncbi.nlm.nih.gov/34961923/", "https://pubmed.ncbi.nlm.nih.gov/34961923/"], ["", "", "Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways:\u00a0https://arxiv.org/abs/2109.00089?fbclid=IwAR2orycgbxqSNXLR9A4XjNwEAZBumiRbRKsfW8KL5qiJCXSWwqmLiMtc4Z4", "https://arxiv.org/abs/2109.00089?fbclid=IwAR2orycgbxqSNXLR9A4XjNwEAZBumiRbRKsfW8KL5qiJCXSWwqmLiMtc4Z4"], ["", "", "Vaccine induced thrombocytopenia and thrombosis: venous endotheliopathy leading to venous combined micro-macrothrombosis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34833382/", "https://pubmed.ncbi.nlm.nih.gov/34833382/"], ["", "", "The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia:\u00a0https://pubmed.ncbi.nlm.nih.gov/34455073/", "https://pubmed.ncbi.nlm.nih.gov/34455073/"], ["", "", "Safety warning for AstraZeneca in patients with sickle cell disease:\u00a0https://mjhid.org/index.php/mjhid/article/view/4708?fbclid=IwAR2kMtsqqwiYyxxQ9XxIvDFdOSt-yTPqjAro-fgaEp460JeHd0QwBxx4DPg", "https://mjhid.org/index.php/mjhid/article/view/4708?fbclid=IwAR2kMtsqqwiYyxxQ9XxIvDFdOSt-yTPqjAro-fgaEp460JeHd0QwBxx4DPg"], ["", "", "Hemolysis "], ["", "", "Post-COVID vaccinationacute hemolysis in an older man:\u00a0https://pubmed.ncbi.nlm.nih.gov/34821933/", "https://pubmed.ncbi.nlm.nih.gov/34821933/"], ["", "", "Autoimmune hemolytic anemia:\u00a0https://pubmed.ncbi.nlm.nih.gov/34150386/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34150386%2F%3Ffbclid%3DIwAR0DWarRs098gYioUVWEWcyo2VyogiVVi3BJDb0z6tZEP0Hm9VQjXhPL2iA&h=AT2Yc0xf-0lle9W46h8Gt4pw77TfyXVvLbenGneVxXvVToGKyEi2Bx1JLhir1oGyE7SF-oRAZ1ufes7r2tgMoHzCEWskxsYoVMlP7uRO49MZUTwX4Jm4LaZeaJNfYPsd3qWNVk4zU_NJ0LPbITOcGA&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "First and fatal case of autoimmune acquired factor XIII/13 deficiency after Pfizer in a 78yoF: https://pubmed.ncbi.nlm.nih.gov/34856014/"], ["", "", "Autoimmune hemolytic anemia following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34258873/", "https://pubmed.ncbi.nlm.nih.gov/34258873/"], ["", "", "Autoimmune hemolytic anemia after Moderna with undetected pernicious anemia: https://pubmed.ncbi.nlm.nih.gov/35103106/"], ["", "", "Cold agglutinin disease in a 45yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34176130/"], ["", "", "Hemolytic crisis in a woman with cold agglutinin disease following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33939851/", "https://pubmed.ncbi.nlm.nih.gov/33939851/"], ["", "", "Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor following Moderna:\u00a0https://onlinelibrary.wiley.com/doi/10.1002/ajh.26262", "https://onlinelibrary.wiley.com/doi/10.1002/ajh.26262"], ["", "", "6 Paraoxysmal nocturnal hemoglobinuria patients with hemolytic crisis following Pfizer and Moderna:\u00a0https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in", "https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in"], ["", "", "Anemia"], ["", "", "Aplastic anemia in a 56yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34920343/"], ["", "", "Aplastic anemia after COVID vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34783367/", "https://pubmed.ncbi.nlm.nih.gov/34783367/"], ["", "", "ITP"], ["", "", "ITP and AIHA following Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274740/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274740/"], ["", "", "95yoM with ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35022338/"], ["", "", "2 cases of ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35022337/"], ["", "", "ITP Exacerbation in previous stable patient following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34307734/", "https://pubmed.ncbi.nlm.nih.gov/34307734/"], ["", "", "ITP relapse post-Pfizer vaccine in a 28yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804803/", "https://pubmed.ncbi.nlm.nih.gov/34804803/"], ["", "", "ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34155844/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34155844%2F%3Ffbclid%3DIwAR1fj5YAs279VLhJZbXsyKTrXw_GFnEHtL-F-HO56KyZMeNTqquty0U-sqs&h=AT2rVHpneF8JD19yYXY6KKgHorCi-ScN0-PWYxCaIrpIMRDcqJ3pfQQ-J1l8yrllG_BVVASZjKJi1zSYa0kU5c9E0VLXWu2BM8auAu2X3zDdvMUPmEcAKjdJK_sDn_w_khcysUgx_YpQS-PQuBPEEQ&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34382388/", "https://pubmed.ncbi.nlm.nih.gov/34382388/"], ["", "", "ITP following booster dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34820240/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34820240/"], ["", "", "Secondary ITP and resulting hemorrhage and hematoma after minor oral surgery after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34314875/", "https://pubmed.ncbi.nlm.nih.gov/34314875/"], ["", "", "ITP and diffuse papular rash following Moderna:\u00a0https://www.scienceopen.com/document_file/691feaa0-8e64-40c4-9553-40382bd5ac48/PubMedCentral/691feaa0-8e64-40c4-9553-40382bd5ac48.pdf", "https://www.scienceopen.com/document_file/691feaa0-8e64-40c4-9553-40382bd5ac48/PubMedCentral/691feaa0-8e64-40c4-9553-40382bd5ac48.pdf"], ["", "", "ITP following Astrazeneca:\u00a0https://ashpublications.org/blood/article/doi/10.1182/blood.2021012790/476455/Immune-Thrombocytopenic-Purpura-after-vaccination", "https://ashpublications.org/blood/article/doi/10.1182/blood.2021012790/476455/Immune-Thrombocytopenic-Purpura-after-vaccination"], ["", "", "ITP in 1st\u00a0trimester of pregnancy 13 days following vaccination in the US:\u00a0https://pubmed.ncbi.nlm.nih.gov/34420249/", "https://pubmed.ncbi.nlm.nih.gov/34420249/"], ["", "", "20yoF with ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34381692/", "https://pubmed.ncbi.nlm.nih.gov/34381692/"], ["", "", "22yoM with\u00a0ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33476455/", "https://pubmed.ncbi.nlm.nih.gov/33476455/"], ["", "", "24yoF with ITP\u00a0following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34754937/", "https://pubmed.ncbi.nlm.nih.gov/34754937/"], ["", "", "25yoF with\u00a0ITP exacerbation following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34660131/", "https://pubmed.ncbi.nlm.nih.gov/34660131/"], ["", "", "26yoF with ITP and acute liver injury following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34330722/", "https://pubmed.ncbi.nlm.nih.gov/34330722/"], ["", "", "26yoF with ITP following Moderna:\u00a0http://pubs.sciepub.com/ajmcr/9/8/3/index.html", "http://pubs.sciepub.com/ajmcr/9/8/3/index.html"], ["", "", "28yoM with ITP following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/33934330/", "https://pubmed.ncbi.nlm.nih.gov/33934330/"], ["", "", "37yoF with ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34732627/", "https://pubmed.ncbi.nlm.nih.gov/34732627/"], ["", "", "39yoF\u00a0with ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34285180/", "https://pubmed.ncbi.nlm.nih.gov/34285180/"], ["", "", "41yoF with secondary ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34059544/", "https://pubmed.ncbi.nlm.nih.gov/34059544/"], ["", "", "41yoM with ITP following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34377889/", "https://pubmed.ncbi.nlm.nih.gov/34377889/"], ["", "", "54yoF with ITP following Pfizer:\u00a0https://www.cureus.com/articles/56899-newly-diagnosed-idiopathic-thrombocytopenia-post-covid-19-vaccine-administration", "https://www.cureus.com/articles/56899-newly-diagnosed-idiopathic-thrombocytopenia-post-covid-19-vaccine-administration"], ["", "", "63yoF with ITP following Johnson and Johnson:\u00a0https://pubmed.ncbi.nlm.nih.gov/34469919/", "https://pubmed.ncbi.nlm.nih.gov/34469919/"], ["", "", "67yoF with ITP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34513446/", "https://pubmed.ncbi.nlm.nih.gov/34513446/"], ["", "", "68yoF\u00a0with ITP in Korea following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34751013/", "https://pubmed.ncbi.nlm.nih.gov/34751013/"], ["", "", "68yoF with ITP following Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385179/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385179/"], ["", "", "69yoF with refractory ITP following Pfizer:\u00a0https://journals.lww.com/americantherapeutics/Citation/2021/08000/Immune_Thrombocytopenic_Purpura_Associated_With.24.aspx", "https://journals.lww.com/americantherapeutics/Citation/2021/08000/Immune_Thrombocytopenic_Purpura_Associated_With.24.aspx"], ["", "", "74yoM with ITP following Moderna:\u00a0https://www.dovepress.com/severe-refractory-immune-thrombocytopenia-occurring-after-sars-cov-2-v-peer-reviewed-fulltext-article-JBM", "https://www.dovepress.com/severe-refractory-immune-thrombocytopenia-occurring-after-sars-cov-2-v-peer-reviewed-fulltext-article-JBM"], ["", "", "84yoM with ITP following Pfizer:\u00a0https://link.springer.com/article/10.1007/s11739-021-02778-w", "https://link.springer.com/article/10.1007/s11739-021-02778-w"], ["", "", "86yoM with ITP following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34446449/", "https://pubmed.ncbi.nlm.nih.gov/34446449/"], ["", "", "2 cases of ITP\u00a0following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34114220/", "https://pubmed.ncbi.nlm.nih.gov/34114220/"], ["", "", "3 cases of ITP following Pfizer and Astra Zeneca:\u00a0https://www.mjhid.org/index.php/mjhid/article/view/4669/4043", "https://www.mjhid.org/index.php/mjhid/article/view/4669/4043"], ["", "", "3 cases reports of ITP following Pfizer and J&J:\u00a0https://ehoonline.biomedcentral.com/articles/10.1186/s40164-021-00235-0", "https://ehoonline.biomedcentral.com/articles/10.1186/s40164-021-00235-0"], ["", "", "Acquired hemophilia A following Pfizer, successfully treated with prednisolone and rituximab: https://pubmed.ncbi.nlm.nih.gov/35088622/"], ["", "", "4 cases of acquired hemophilia A after Pfizer: https://pubmed.ncbi.nlm.nih.gov/35081484/"], ["", "", "3 cases:\u00a0recurrent AvWD and acquired hemophilia A after Moderna, PNH flare following Moderna, and ITP flare following Moderna:\u00a0https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic", "https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic"], ["", "", "3 cases of acquired hemophilia A after mRNA vaccine, investigation into possible mechanism: https://pubmed.ncbi.nlm.nih.gov/35108443/"], ["", "", "3 cases of ITP, 2 in chronic individuals and 1 in a healthy individual, following Pfizer and Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34716890/", "https://pubmed.ncbi.nlm.nih.gov/34716890/"], ["", "", "10 cases of ITP following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35108113/"], ["", "", "3 cases of ITP in elderly patients following vaccination:\u00a0https://www.hindawi.com/journals/crihem/2016/7913092/", "https://www.hindawi.com/journals/crihem/2016/7913092/"], ["", "", "4 cases of severe ITP following Pfizer, Moderna, and AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34653943/", "https://pubmed.ncbi.nlm.nih.gov/34653943/"], ["", "", "20 cases of ITP following Pfizer and Moderna vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33606296/", "https://pubmed.ncbi.nlm.nih.gov/33606296/"], ["", "", "21 cases of ITP\u00a0following Pfizer and AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34756770/", "https://pubmed.ncbi.nlm.nih.gov/34756770/"], ["", "", "36 Cases of ITP following Pfizer and Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/"], ["", "", "77 denovo cases\u00a0of ITP and 19 ITP exacerbation following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34587251/", "https://pubmed.ncbi.nlm.nih.gov/34587251/"], ["", "", "12% of chronic ITP patients have exacerbation of ITP in 2-5 days following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34075578/", "https://pubmed.ncbi.nlm.nih.gov/34075578/"], ["", "", "Throbolytic / Thrombocytopenia"], ["", "", "CoV-2 vaccination\u00a0in patients with autoimmune cytopenias: the experience of a reference center:\u00a0https://pubmed.ncbi.nlm.nih.gov/34478178/", "https://pubmed.ncbi.nlm.nih.gov/34478178/"], ["", "", "PE, TIA, and thrombocytopenia after J&J:\u00a0https://pubmed.ncbi.nlm.nih.gov/34261635/", "https://pubmed.ncbi.nlm.nih.gov/34261635/"], ["", "", "Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265377/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265377/"], ["", "", "DVT and PE and positive HIT panel following mRNA Vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34117206/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34117206%2F%3Ffbclid%3DIwAR3AiLwagRAVJPbwBl6OuqhD6Bfiv3Zv-_dmZyxtps4YVo51_4DeUgdgNlg&h=AT2gsGlO3racL9Ei_LpeDM_aDuq3QkgxJTivAptcN4zAHFgqQlgswqUoO-mKcSfwTKKUQ8LW9f9rI05fcpUSp2xrLqESv2bQ69utcjOTYjCvXEpw8deQQ0NQhfYfEmf8xwDFPc48KAftyil8coa5Gg&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "An unusual presentation of acute DVT after moderna vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34790811/", "https://pubmed.ncbi.nlm.nih.gov/34790811/"], ["", "", "3 patients with venous thromboembolism following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34352418/", "https://pubmed.ncbi.nlm.nih.gov/34352418/"], ["", "", "Thrombosis with Thrombocytopenia following Moderna:\u00a0https://www.acpjournals.org/doi/full/10.7326/L21-0244", "https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.acpjournals.org%2Fdoi%2Ffull%2F10.7326%2FL21-0244%3Ffbclid%3DIwAR0ZEVWMJWhR4Tu0_yvWz0Oe8sIDGU3e-9S1ZiUT9cvRgzOUiIk_oSvbc0E&h=AT31fBM16ST0NKfP4yNAI0EsIH1-Cbx6srE8v748oGCEXFGI2cswDIVOO8ZpQKPiytd7SwTMyG4f7CVGbb2wfZBpVwltZiylthsk1mkjgpcY3nzpEdqx0IeKIv3_k4y8g-ZwpWwkOWXzfXe8_AHgYg&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "34yoF with vaccine induced thrombotic thrombocytopenia following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804389/", "https://pubmed.ncbi.nlm.nih.gov/34804389/"], ["", "", "Thrombotic thrombocytopenia following Pfizer vaccination in a Japanese Patient:\u00a0https://pubmed.ncbi.nlm.nih.gov/34803105/", "https://pubmed.ncbi.nlm.nih.gov/34803105/"], ["", "", "Case report: vaccine-induced immune thrombotic thrombocytopenia in a pancreatic cancer patient after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34790684/", "https://pubmed.ncbi.nlm.nih.gov/34790684/"], ["", "", "Case study of Thrombosis and Thrombocytopenia following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34781321/", "https://pubmed.ncbi.nlm.nih.gov/34781321/"], ["", "", "Eltromopag for refractory vaccine-induced immune thrombotic thrombocytopenia in a 64yoF following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34797474/", "https://pubmed.ncbi.nlm.nih.gov/34797474/"], ["", "", "TTP Following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34264514/", "https://pubmed.ncbi.nlm.nih.gov/34264514/"], ["", "", "Acquired TTP following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34309715/", "https://pubmed.ncbi.nlm.nih.gov/34309715/"], ["", "", "TTP in a 25yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34895163/"], ["", "", "Clinical relapse of immune mediated TTP in a 28yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35155977/"], ["", "", "Denovo iTTP episode in a 38yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34105244/"], ["", "", "Acquired TTP in a 61yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34909764/"], ["", "", "Case series of patients who developed acquired TTP within several days of Pfizer"], ["", "", "TTP in an adolescent following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34405400/", "https://pubmed.ncbi.nlm.nih.gov/34405400/"], ["", "", "Flare of compensated congenital TTP following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34693915/", "https://pubmed.ncbi.nlm.nih.gov/34693915/"], ["", "", "Thrombocytopenia in a teen with sickle cell disease following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34331506/", "https://pubmed.ncbi.nlm.nih.gov/34331506/"], ["", "", "5 cases of prothrombotic immune thrombocytopenia after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34323939/", "https://pubmed.ncbi.nlm.nih.gov/34323939/"], ["", "", "20 cases of Thrombocytopenia following Pfizer and Moderna:\u00a0https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132", "https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132"], ["", "", "Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34332437/", "https://pubmed.ncbi.nlm.nih.gov/34332437/"], ["", "", "68yoF with extensive thrombosis after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34400433/", "https://pubmed.ncbi.nlm.nih.gov/34400433/"], ["", "", "Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings:\u00a0https://pubmed.ncbi.nlm.nih.gov/34355379/", "https://pubmed.ncbi.nlm.nih.gov/34355379/"], ["", "", "Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34402235/", "https://pubmed.ncbi.nlm.nih.gov/34402235/"], ["", "", "Five cases with a combination of cerebral venous thrombosis, intracerebral hemorrhage and thrombocytopenia following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34393988/", "https://pubmed.ncbi.nlm.nih.gov/34393988/"], ["", "", "VITT"], ["", "", "Late Onset VITT with cerebral venous sinus thrombosis: https://pubmed.ncbi.nlm.nih.gov/35093626/"], ["", "", "Confusion and abdominal pain due to VITT following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34346657/", "https://pubmed.ncbi.nlm.nih.gov/34346657/"], ["", "", "Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34344867/", "https://pubmed.ncbi.nlm.nih.gov/34344867/"], ["", "", "Malignant CVA due to VITT following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34341358/", "https://pubmed.ncbi.nlm.nih.gov/34341358/"], ["", "", "3 cases of immune thrombocytopenia following AstraZeneca in Thailand:\u00a0https://pubmed.ncbi.nlm.nih.gov/34483267/", "https://pubmed.ncbi.nlm.nih.gov/34483267/"], ["", "", "Other:"], ["", "", "New onset evans syndrome associated with systemic lupus erythematosus after Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34687421/", "https://pubmed.ncbi.nlm.nih.gov/34687421/"], ["", "", "Skin, nose, and gingival bleeding episodes after AstraZeneca: a large population-based cohort study:\u00a0https://pubmed.ncbi.nlm.nih.gov/34479760/", "https://pubmed.ncbi.nlm.nih.gov/34479760/"], ["", "", "Haemophagocytosis and atypical lymphocytes on bone marrow biopsy following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34312842/", "https://pubmed.ncbi.nlm.nih.gov/34312842/"], ["", "", "3 cases of HLH following AstraZeneca:\u00a0https://jcp.bmj.com/content/early/2021/07/22/jclinpath-2021-207760", "https://jcp.bmj.com/content/early/2021/07/22/jclinpath-2021-207760"], ["", "", "Idiopathic ipsilateral external\u00a0jugular vein thrombophlebitis after Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33624509/", "https://pubmed.ncbi.nlm.nih.gov/33624509/"], [], ["", "", "Oncology", "Oncology"], ["", "", "General"], ["", "", "Temporal metabolic response to mRNA vaccinations in oncology patients:\u00a0https://pubmed.ncbi.nlm.nih.gov/34463888/", "https://pubmed.ncbi.nlm.nih.gov/34463888/"], ["", "", "Coordination and optimization of FDG PET/CT and vaccination; lessons learned in the early stages of mass vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34029956/", "https://pubmed.ncbi.nlm.nih.gov/34029956/"], ["", "", "Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34432391/", "https://pubmed.ncbi.nlm.nih.gov/34432391/"], ["", "", "Axillary lymphadenopathy after vaccination in a woman with breast cancer: https://pubmed.ncbi.nlm.nih.gov/34940788/"], ["", "", "Fine needle aspiration in a vaccine associated lymphadenopathy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34286849/", "https://pubmed.ncbi.nlm.nih.gov/34286849/"], ["", "", "Hypermetabolic lymphadenopathy following Pfier, incidence assessed by FDG PET-CT and revelance to study interpretation, a review of 728 vaccinated patients:\u00a0https://pubmed.ncbi.nlm.nih.gov/33774684/", "https://pubmed.ncbi.nlm.nih.gov/33774684/"], ["", "", "Lympadenopathy / Adenopathy:"], ["", "", "Lymphadenopathy following vaccination: imaging findings review:\u00a0https://pubmed.ncbi.nlm.nih.gov/33985872/", "https://pubmed.ncbi.nlm.nih.gov/33985872/"], ["", "", "Axillary lymphadenopathy following mRNA vaccination", "Axillary lymphadenopathy following mRNA vaccination:"], ["", "", "Ipsilateral axillary adenopathy following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34333959/", "https://pubmed.ncbi.nlm.nih.gov/34333959/"], ["", "", "Deep axillary lymphadenopathy after vaccination: a case report:\u00a0https://pubmed.ncbi.nlm.nih.gov/34694537/", "https://pubmed.ncbi.nlm.nih.gov/34694537/"], ["", "", "Unilateral axillary lymphadenopathy following vaccination: a case report and imaging findings:\u00a0https://pubmed.ncbi.nlm.nih.gov/33868525/", "https://pubmed.ncbi.nlm.nih.gov/33868525/"], ["", "", "Unilateral axillary lymphadenopathy after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33617289/", "https://pubmed.ncbi.nlm.nih.gov/33617289/"], ["", "", "Axillary adenopathy following vaccination, a new diagnostic dilemma:\u00a0https://pubmed.ncbi.nlm.nih.gov/34825530/", "https://pubmed.ncbi.nlm.nih.gov/34825530/"], ["", "", "Unilateral axillary adenopathy in the setting of covid-19 vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/33486146/", "https://pubmed.ncbi.nlm.nih.gov/33486146/"], ["", "", "Unilateral axillary adenopathy following vaccination: a multimodality pictorial illustration and review of current guidelines:\u00a0https://pubmed.ncbi.nlm.nih.gov/34053731/", "https://pubmed.ncbi.nlm.nih.gov/34053731/"], ["", "", "False positive axillary lymph nodes on FDG PET/CT resulting from covid-19 immunization:https://pubmed.ncbi.nlm.nih.gov/33883486/", "https://pubmed.ncbi.nlm.nih.gov/33883486/"], ["", "", "4 cases of axillary adenopathy following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34303188/", "https://pubmed.ncbi.nlm.nih.gov/34303188/"], ["", "", "COVID-19 vaccination associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women:\u00a0https://pubmed.ncbi.nlm.nih.gov/33624520/", "https://pubmed.ncbi.nlm.nih.gov/33624520/"], ["", "", "163 cases of axillary adenopathy following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34257025/", "https://pubmed.ncbi.nlm.nih.gov/34257025/"], ["", "", "mRNA vaccination: age and immune status and its association with axillar lymph node PET/CT uptake, a review of 426 patients:\u00a0https://pubmed.ncbi.nlm.nih.gov/33893188/", "https://pubmed.ncbi.nlm.nih.gov/33893188/"], ["", "", "Ipsilateral avid axillary lymph node update at FDG PET/CT persists in 29% of patients 7-10 weeks after 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33904778/", "https://pubmed.ncbi.nlm.nih.gov/33904778/"], ["", "", "Incidence of axillary adenopathy on Breast Imaging following Vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34292295/", "https://pubmed.ncbi.nlm.nih.gov/34292295/"], ["", "", "Breast radiation recall phenomena after AstraZeneca: A case series: https://pubmed.ncbi.nlm.nih.gov/35103229/"], ["", "", "Regional lymphadenopathy following vaccination: literature review and considerations for patient management in breast cancer care:\u00a0https://pubmed.ncbi.nlm.nih.gov/34731748/", "https://pubmed.ncbi.nlm.nih.gov/34731748/"], ["", "", "Axillary lymphadenopathy at the time of vaccination: ten recommendations from the European society of breast imaging:\u00a0https://pubmed.ncbi.nlm.nih.gov/34417642/", "https://pubmed.ncbi.nlm.nih.gov/34417642/"], ["", "", "Evolving bilateral hypermetabolic axillary lymphadenopathy on FDG PET/CT following 2-dose COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34735411/", "https://pubmed.ncbi.nlm.nih.gov/34735411/"], ["", "", "Axillary lymph nodes hypermetabolism after Pfizer in cancer patients underoing 18F-FDG PET/CT: a cohort study:https://pubmed.ncbi.nlm.nih.gov/33782299/", "https://pubmed.ncbi.nlm.nih.gov/33782299/"], ["", "", "Reactive axillary lymphadenopathy to covid-19 vaccination on F-FDG PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/33820864/", "https://pubmed.ncbi.nlm.nih.gov/33820864/"], ["", "", "Association of COVID-19 mRNA vaccine with ipsilateral axillary node reactivity on imaging:\u00a0https://pubmed.ncbi.nlm.nih.gov/34110378/", "https://pubmed.ncbi.nlm.nih.gov/34110378/"], ["", "", "Supraclavicular lymphadenopathy following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34414929/", "https://pubmed.ncbi.nlm.nih.gov/34414929/"], ["", "", "Rare case of contralateral supraclavicular lymphadenopathy after vaccination: CT and ultrasound findings:https://pubmed.ncbi.nlm.nih.gov/34667486/", "https://pubmed.ncbi.nlm.nih.gov/34667486/"], ["", "", "Supraclavicular lymphadenopathy after vaccination in Korea: a serial follow-up using ultrasonography:https://pubmed.ncbi.nlm.nih.gov/34116295/", "https://pubmed.ncbi.nlm.nih.gov/34116295/"], ["", "", "Supraclavicular lymphadenopathy following vaccination: an increasing presentation to the two-week wait neck lump clinic?\u00a0https://pubmed.ncbi.nlm.nih.gov/33685772/", "https://pubmed.ncbi.nlm.nih.gov/33685772/"], ["", "", "Vaccination and low cervical lymphadenopathy in the two week neck lump clinic- a follow up audit:\u00a0https://pubmed.ncbi.nlm.nih.gov/33947605/", "https://pubmed.ncbi.nlm.nih.gov/33947605/"], ["", "", "Cervical lymphadenopathy following Pfizer", "Cervical lymphadenopathy following Pfizer:"], ["", "", "13 cases of Cervical lymphadenopathy:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/?fbclid=IwAR1rNNNUQeLu0rKsy9H_9WSu6FuaW4i9AlPiXfbLMP3CAhJJrWzJH8PRP4c"], ["", "", "50yoM with adenopathy following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34406229/", "https://pubmed.ncbi.nlm.nih.gov/34406229/"], ["", "", "Review of 24 cases of lymphadenopathy and their ultrasound findings in the US:\u00a0https://pubmed.ncbi.nlm.nih.gov/34356507/", "https://pubmed.ncbi.nlm.nih.gov/34356507/"], ["", "", "Kikucki-Fujimoto disease following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34395192/", "https://pubmed.ncbi.nlm.nih.gov/34395192/"], ["", "", "2 cases of\u00a0Kikuchi-Fujimoto Disease\u00a0following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34835182/", "https://pubmed.ncbi.nlm.nih.gov/34835182/"], ["", "", "Mammographic and sonographic findings in the breast and axillary tail following vaccination:https://pubmed.ncbi.nlm.nih.gov/34340203/", "https://pubmed.ncbi.nlm.nih.gov/34340203/"], ["", "", "Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of covid-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33543649/", "https://pubmed.ncbi.nlm.nih.gov/33543649/"], ["", "", "Mitigating the impact of COVID-19 vaccinations on patients undergoing breast imaging examinations: a pragmatic approach:\u00a0https://pubmed.ncbi.nlm.nih.gov/33617288/", "https://pubmed.ncbi.nlm.nih.gov/33617288/"], ["", "", "COVID-19 vaccine related axillary and cervical lymphadenopathy in patients with current or prior breast cancer and other malignancies: cross sectional imaging findings on MRI, CT, and PET-CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/34719892/", "https://pubmed.ncbi.nlm.nih.gov/34719892/"], ["", "", "The challenge of staging breast cancer with PET/CT in the era of covid vaccination:https://pubmed.ncbi.nlm.nih.gov/33795590/", "https://pubmed.ncbi.nlm.nih.gov/33795590/"], ["", "", "Vaccination and breast cancer surgery timing:\u00a0https://pubmed.ncbi.nlm.nih.gov/34156582/", "https://pubmed.ncbi.nlm.nih.gov/34156582/"], ["", "", "Vaccine related unilateral axillary lymphadenopathy: pattern on screening breast MRI:\u00a0https://pubmed.ncbi.nlm.nih.gov/34325221/", "https://pubmed.ncbi.nlm.nih.gov/34325221/"], ["", "", "Evolution of lymphadenopathy at PET/MRI after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310229/", "https://pubmed.ncbi.nlm.nih.gov/34310229/"], ["", "", "Axillary lymphadenopathy after COVID vaccination in patients with thoracic malignancy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34506955/", "https://pubmed.ncbi.nlm.nih.gov/34506955/"], ["", "", "DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson:\u00a0https://pubmed.ncbi.nlm.nih.gov/34269723/", "https://pubmed.ncbi.nlm.nih.gov/34269723/"], ["", "", "DOTATATE-avid bilateral axillar and subpectoral lymphadenopathy induced from mRNA vaccination visualized on PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/33795589/", "https://pubmed.ncbi.nlm.nih.gov/33795589/"], ["", "", "DOTATOC-avid lymphadenopathies induced by mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34363083/", "https://pubmed.ncbi.nlm.nih.gov/34363083/"], ["", "", "3 cases of supraclavicular and axillary lymphadenopathy induced by vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/34507331/\u00a0\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34507331/"], ["", "", "FDG uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma:\u00a0https://pubmed.ncbi.nlm.nih.gov/34412144/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34412144/"], ["", "", "Moderna vaccination mimicking lymph-node progression in a patient with melanoma:\u00a0https://pubmed.ncbi.nlm.nih.gov/34433198/", "https://pubmed.ncbi.nlm.nih.gov/34433198/"], ["", "", "COVID-19 vaccine as cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma:\u00a0https://pubmed.ncbi.nlm.nih.gov/33675368/", "https://pubmed.ncbi.nlm.nih.gov/33675368/"], ["", "", "Pfizer vaccination manifesting as incidental lymph node uptake on 18F-FDG PET/CT in a melanoma patient:\u00a0https://pubmed.ncbi.nlm.nih.gov/33661193/", "https://pubmed.ncbi.nlm.nih.gov/33661193/"], ["", "", "Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient:\u00a0https://pubmed.ncbi.nlm.nih.gov/34414110/", "https://pubmed.ncbi.nlm.nih.gov/34414110/"], ["", "", "8 patients where mRNA vaccine mimics lymph node metastates in patients undergoing skin cancer follow-up:\u00a0https://pubmed.ncbi.nlm.nih.gov/34280870/", "https://pubmed.ncbi.nlm.nih.gov/34280870/"], ["", "", "Hypermetabolic reactive lymphadenopathy following 3rd\u00a0COVID-19 vaccination in a breast cancer patient and a patient with squamous cell carcinoma of the head and neck:\u00a0https://pubmed.ncbi.nlm.nih.gov/34746900/", "https://pubmed.ncbi.nlm.nih.gov/34746900/"], ["", "", "False Positive FDG PET CT after vaccination in a woman treated for metastatic breast cancer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34308402/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34308402/"], ["", "", "COVID-19 vaccine related axillary lymphadenopathy in breast cancer patients: case series with a review of the literature:\u00a0https://pubmed.ncbi.nlm.nih.gov/34836672/", "https://pubmed.ncbi.nlm.nih.gov/34836672/"], ["", "", "Pfizer vaccine related local FDG uptake in a lymphoma patient:\u00a0https://pubmed.ncbi.nlm.nih.gov/33661194/", "https://pubmed.ncbi.nlm.nih.gov/33661194/"], ["", "", "mRNA vaccination induced lymphadenopathy mimics lymphoma progression on FDG PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/33591026/", "https://pubmed.ncbi.nlm.nih.gov/33591026/"], ["", "", "Avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34269722/", "https://pubmed.ncbi.nlm.nih.gov/34269722/"], ["", "", "Limiting screening mammography recalls for vaccine-induced adenopathy, a single institution experience: https://pubmed.ncbi.nlm.nih.gov/35090829/"], ["", "", "FDG-PET / PET-CT findings:"], ["", "", "Vaccination effect on tracer uptake with FDG-PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/34297113/", "https://pubmed.ncbi.nlm.nih.gov/34297113/"], ["", "", "18-FDG-Avid lymph nodes after covid-19 vaccination on PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/33782318/", "https://pubmed.ncbi.nlm.nih.gov/33782318/"], ["", "", "18-FDG-Avid lymph nodes after covid-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33741644/", "https://pubmed.ncbi.nlm.nih.gov/33741644/"], ["", "", "FDG update in axillary lymph nodes and deltoid muscle after mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis: https://pubmed.ncbi.nlm.nih.gov/35098436/"], ["", "", "COVID-19 vaccination induced axillary nodal update on 18F FDG PET/CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/33638003/", "https://pubmed.ncbi.nlm.nih.gov/33638003/"], ["", "", "Prevelance and significance of hypermetabolic lymph nodes detected by 18F FDG PET/CT after vaccination: a systematic review and meta-analysis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34451859/", "https://pubmed.ncbi.nlm.nih.gov/34451859/"], ["", "", "AstraZeneca vaccination included lymphadenopathy on 18F choline PET/CT-not only an FDG finding:\u00a0https://pubmed.ncbi.nlm.nih.gov/33661328/", "https://pubmed.ncbi.nlm.nih.gov/33661328/"], ["", "", "Abnormal PET following vaccination:\u00a0https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.29262", "https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.29262"], ["", "", "Positive PET following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34301777/", "https://pubmed.ncbi.nlm.nih.gov/34301777/"], ["", "", "Vaccine related lymph node activation-patterns of uptake on PET-CT:\u00a0https://pubmed.ncbi.nlm.nih.gov/34131510/", "https://pubmed.ncbi.nlm.nih.gov/34131510/"], ["", "", "Lymphadenopathy in vaccine recipients: a diagnostic dilemma in oncologic patients:\u00a0https://pubmed.ncbi.nlm.nih.gov/33625300/", "https://pubmed.ncbi.nlm.nih.gov/33625300/"], ["", "", "The day after mass COVID vaccination: higher hypermetabolic lymphadenopathy detection on PET/CT and impact on oncologic management:\u00a0https://pubmed.ncbi.nlm.nih.gov/34503150/", "https://pubmed.ncbi.nlm.nih.gov/34503150/"], ["", "", "Frequency and characteristics of nodal and deltoid FDG and C-Choline update on PET performed after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34009000/", "https://pubmed.ncbi.nlm.nih.gov/34009000/"], ["", "", "COVID-19 vaccination-related update on FDG PET/CT: an emerging dilemma and suggestions for management:https://pubmed.ncbi.nlm.nih.gov/33646823/", "https://pubmed.ncbi.nlm.nih.gov/33646823/"], ["", "", "Subcutaneous uptake on 18F PET/CT: a case report of possible amyloid-beta immune-reactivity after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34541458/", "https://pubmed.ncbi.nlm.nih.gov/34541458/"], ["", "", "Rapid progression of Angioimmunoblastic t cell lymphoma following Pfizer Booster: https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full?fbclid=IwAR3N-pwv8MMsjpNgb3DeEQQ5GYEGmYBQDVveSbHXvg_y5kLHDYw_2EgNsns"], ["", "", "Lymphoma"], ["", "", "Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full"], ["", "", "Other:"], ["", "", "Thymic hyperplasia after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34462647/", "https://pubmed.ncbi.nlm.nih.gov/34462647/"], ["", "", "Fatal systemic capillary leak syndrome after Johnson and Johnson vaccination in a multiple myeloma patient:\u00a0https://pubmed.ncbi.nlm.nih.gov/34459725/", "https://pubmed.ncbi.nlm.nih.gov/34459725/"], ["", "", "Rituximab-induced acute lympholysis and pancytopenia after Moderna in a 71yoM with b-cell lymphoplasmacytic lymphoma:\u00a0https://pubmed.ncbi.nlm.nih.gov/34429981/", "https://pubmed.ncbi.nlm.nih.gov/34429981/"], ["", "", "Adverse reactions following vaccination in patients with cancer undergoing treatment:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527840/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527840/"], ["", "", "3 cases of Interstitial Pneumonitis after COVID-19 vaccination: https://pubmed."], ["", "", "Rapid development of radiation recall pneumonitis in a non-small cell lung cancer patient immediately following second dose of Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/33968515/", "https://pubmed.ncbi.nlm.nih.gov/33968515/"], ["", "", "Radiation recall pneumonitis on FDG/ PET/CT triggered by mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34739397/", "https://pubmed.ncbi.nlm.nih.gov/34739397/"], ["", "", "Radiation recall pneumonitis in a non-small cell lung cancer patient following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34791816/", "https://pubmed.ncbi.nlm.nih.gov/34791816/"], [], ["", "", "Dermatology/Plastics:", "Dermatology/Plastics:"], ["", "", "2 cases of denovo dermatomyositis and inflammatory myositis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35094715/"], ["", "", "Dermatomyositis-like rash and inflammatory myopathy after Moderna: https://pubmed.ncbi.nlm.nih.gov/35048951/"], ["", "", "Dermatomyositis following Pfizer vaccination in a 43yoF: https://pubmed.ncbi.nlm.nih.gov/35132838/"], ["", "", "Unilateral linear purpuric rash heralding AstraZeneca induced ITP: https://pubmed.ncbi.nlm.nih.gov/35176191/"], ["", "", "60yo with Steven Johnson Syndrome:\u00a0https://pubmed.ncbi.nlm.nih.gov/34081806/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34081806%2F%3Ffbclid%3DIwAR2vLb7_717NHb889F8IHkv_E_ncboUBlmTVdeOd1eKP-BBS8bovQFQMRn0&h=AT3FvmitWyRWEzrFhhIQ0DXbVA3yAIUTQ5W_ZyzUSQQPcDx_hqRo_QZp9ICvpkoAgHm95j1pypi52HhMlG8eJ5KRShLOhwE9-CXUzX0TcrJmvnuOR9HFe9J4ep6qHF2RDrksRwOsthRCNd0ezj0w0Q&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Steven Johnson Syndrome following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34384729/", "https://pubmed.ncbi.nlm.nih.gov/34384729/"], ["", "", "Pemphigus Vulgaris", "Pemphigus Vulgaris:"], ["", "", "Pemphigus vulgaris after COVID-19 vaccination: one new onset and two cases with severe aggravation: https://pubmed.ncbi.nlm.nih.gov/35187768/"], ["", "", "An unusual presentation of pemphigus foliaceus following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34817063/", "https://pubmed.ncbi.nlm.nih.gov/34817063/"], ["", "", "Morbilliform Rash", "Morbilliform Rash:"], ["", "", "A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34821411/", "https://pubmed.ncbi.nlm.nih.gov/34821411/"], ["", "", "Spontaneous urticaria after Pfizer vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34692313/", "https://pubmed.ncbi.nlm.nih.gov/34692313/"], ["", "", "Pityriasis-rosea like eruption post-vaccination in a young male:\u00a0https://pubmed.ncbi.nlm.nih.gov/34165237/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34165237%2F%3Ffbclid%3DIwAR2XdbC6j_HBLA2qFcY7VPUvsauAKWzTfdDJrTlJBwReMXVwnuexMr8NF58&h=AT0MbefCO_wvccIY4ydSuHnPNlCSYPUWLOMysOvQIzpPlUaxAieIw20L8Ise_0HW_OkEJnzq2XAGIW-CvLvWeXvgIhxh6XjoNcc84FRosCUPgptRVVo9ptuTJNENYpVAcw-JI8or_GpbpGTxnzuxdA&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Pityriasis rosea, pityriasis rosea-like eruptions and herpes zoster after covid-19 and covid-19 vaccination:https://pubmed.ncbi.nlm.nih.gov/35093476/"], ["", "", "Pityriasis rosea following Pfizer:\u00a0\u00a0https://onlinelibrary.wiley.com/doi/10.1111/jdv.17498", "https://onlinelibrary.wiley.com/doi/10.1111/jdv.17498"], ["", "", "Pityriasis lichenoides et varioliformis acuta after SARS-CoV2 infection a relapse after vaccination: https://pubmed.ncbi.nlm.nih.gov/35184341/"], ["", "", "19yoM with Pityriasis rosea following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34374333/", "https://pubmed.ncbi.nlm.nih.gov/34374333/"], ["", "", "29yoM with Pityriasis rosea after Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34740803/", "https://pubmed.ncbi.nlm.nih.gov/34740803/"], ["", "", "35yoM with Pityriasis rosea-like eruption after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33904157/", "https://pubmed.ncbi.nlm.nih.gov/33904157/"], ["", "", "40yoM with Pityriasis rosea after Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34110010/", "https://pubmed.ncbi.nlm.nih.gov/34110010/"], ["", "", "66yoM with Pityriasis rosea after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34435935/", "https://pubmed.ncbi.nlm.nih.gov/34435935/"], ["", "", "1 case of Pityriasis rosea and 3 cases of urticaria following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34478204/", "https://pubmed.ncbi.nlm.nih.gov/34478204/"], ["", "", "2 cases of Pityriasis rosea-like eruptions following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33982814/", "https://pubmed.ncbi.nlm.nih.gov/33982814/"], ["", "", "Pityriasis rosea following Moderna vaccination, a case series:\u00a0https://pubmed.ncbi.nlm.nih.gov/34816549/", "https://pubmed.ncbi.nlm.nih.gov/34816549/"], ["", "", "Vaccine induced Pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature:\u00a0https://pubmed.ncbi.nlm.nih.gov/25545307/", "https://pubmed.ncbi.nlm.nih.gov/25545307/"], ["", "", "Two cases of papulo-pustular rosacea-like eruptions following Pfizer and AstraZeneca:\u00a0\u00a0https://pubmed.ncbi.nlm.nih.gov/34416044/", "https://pubmed.ncbi.nlm.nih.gov/34416044/"], ["", "", "Pityriasis rubra pilaris following Astra Zeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310778/", "https://pubmed.ncbi.nlm.nih.gov/34310778/"], ["", "", "Pityriasis rubra pilaris in 72yoM following Astra Zeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34420983/", "https://pubmed.ncbi.nlm.nih.gov/34420983/"], ["", "", "Pityriasis Rubra Pilaris like eruption following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34379821/", "https://pubmed.ncbi.nlm.nih.gov/34379821/"], ["", "", "Lymphomatoid drug reaction developed after Pfizer vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption:\u00a0https://pubmed.ncbi.nlm.nih.gov/34751995/", "https://pubmed.ncbi.nlm.nih.gov/34751995/"], ["", "", "Lichenoid drug eruption following Pfizer:  https://pubmed.ncbi.nlm.nih.gov/35097176/"], ["", "", "Lichenoid drug\u00a0eruption after COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34961975/", "https://pubmed.ncbi.nlm.nih.gov/34961975/"], ["", "", "3 cases of new onset acral hand lesions following mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310777/", "https://pubmed.ncbi.nlm.nih.gov/34310777/"], ["", "", "2 patients with\u00a0eczematous cutaneous reactions\u00a0following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34236729/", "https://pubmed.ncbi.nlm.nih.gov/34236729/"], ["", "", "Case study of 19 patients with cutaneous adverse reactions following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34698094/", "https://pubmed.ncbi.nlm.nih.gov/34698094/"], ["", "", "New onset synovitis and palmoplantar psoriasis flare up after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34236728/", "https://pubmed.ncbi.nlm.nih.gov/34236728/"], ["", "", "Exacerbation of Hailey-Hailey Disease following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34436620/", "https://pubmed.ncbi.nlm.nih.gov/34436620/"], ["", "", "New onset lichen planus following Pfizer:\u00a0https://onlinelibrary.wiley.com/doi/10.1111/jdv.17504", "https://onlinelibrary.wiley.com/doi/10.1111/jdv.17504"], ["", "", "COVID-vaccine\u00a0induced lichen planus on areas previously affected by vitiligo:https://onlinelibrary.wiley.com/doi/10.1111/jdv.17687", "https://onlinelibrary.wiley.com/doi/10.1111/jdv.17687"], ["", "", "Lichen striatus:\u00a0https://pubmed.ncbi.nlm.nih.gov/34423105/", "https://pubmed.ncbi.nlm.nih.gov/34423105/"], ["", "", "Lichen planus flare following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34934493/"], ["", "", "Purpura annularis telangiectodes following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34236717/", "https://pubmed.ncbi.nlm.nih.gov/34236717/"], ["", "", "Flagellate Purpura following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34416052/", "https://pubmed.ncbi.nlm.nih.gov/34416052/"], ["", "", "Pigmented purpuric dermatosis after Pfizer vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34791786/", "https://pubmed.ncbi.nlm.nih.gov/34791786/"], ["", "", "Symmetrical drug related intertriginous and flexural exanthema like eruption following AztraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34399001/", "https://pubmed.ncbi.nlm.nih.gov/34399001/"], ["", "", "Vitiligo following Pfizer:\u00a0https://onlinelibrary.wiley.com/doi/10.1111/ced.14842", "https://onlinelibrary.wiley.com/doi/10.1111/ced.14842"], ["", "", "Vitiligo in a Ulcerative Colitis Patient following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34498300/", "https://pubmed.ncbi.nlm.nih.gov/34498300/"], ["", "", "Bacillus Calmette-Guerin scar flare after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34344774/", "https://pubmed.ncbi.nlm.nih.gov/34344774/"], ["", "", "Palms and Soles Itchiness following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34391695/", "https://pubmed.ncbi.nlm.nih.gov/34391695/"], ["", "", "Resistant pruritis skin rash following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34358176/", "https://pubmed.ncbi.nlm.nih.gov/34358176/"], ["", "", "Necrotic eschars at injection sites one week after 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34337117/", "https://pubmed.ncbi.nlm.nih.gov/34337117/"], ["", "", "Acral hemorrhage after second dose of vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34697597/", "https://pubmed.ncbi.nlm.nih.gov/34697597/"], ["", "", "Facial Pustular Neutrophilic Eruption following mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34319363/", "https://pubmed.ncbi.nlm.nih.gov/34319363/"], ["", "", "Acute generalized exanthematous pustulosis induced by Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34466640/", "https://pubmed.ncbi.nlm.nih.gov/34466640/"], ["", "", "AstraZeneca induced acute localized exanthematous pustulosis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34487574/", "https://pubmed.ncbi.nlm.nih.gov/34487574/"], ["", "", "Delayed local skin reactions:\u00a0https://www.nejm.org/doi/full/10.1056/NEJMc2102131?fbclid=IwAR0P6wjXiO4swT4wz0lEJCBx7v14e2Si-O9AbOuhlVisVHFhc_kGEy7pyj0", "https://www.nejm.org/doi/full/10.1056/NEJMc2102131?fbclid=IwAR0P6wjXiO4swT4wz0lEJCBx7v14e2Si-O9AbOuhlVisVHFhc_kGEy7pyj0"], ["", "", "Delayed skin reactions following mRNA vaccine:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288253/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288253/"], ["", "", "11 patients with delayed skin reaction after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34433495/", "https://pubmed.ncbi.nlm.nih.gov/34433495/"], ["", "", "Additional 12 Patients with Delayed Local Reactions:\u00a0https://www.nejm.org/doi/full/10.1056/NEJMc2102131", "https://www.nejm.org/doi/full/10.1056/NEJMc2102131"], ["", "", "16 patients delayed hypersensitivity reactions after Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/33978670/", "https://pubmed.ncbi.nlm.nih.gov/33978670/"], ["", "", "138 Delayed Hypersensitivity Reactions following vaccination:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294276/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294276/"], ["", "", "Delayed local Hypersensitivity reactions: a 6 month retrospective study:\u00a0https://pubmed.ncbi.nlm.nih.gov/34288056/", "https://pubmed.ncbi.nlm.nih.gov/34288056/"], ["", "", "Delayed cutaneous hypersensitivity reaction following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34351606/", "https://pubmed.ncbi.nlm.nih.gov/34351606/"], ["", "", "Cutaneous skin manifestation following Moderna with Hypersensitivity reaction Histopathology:\u00a0https://pubmed.ncbi.nlm.nih.gov/34414254/", "https://pubmed.ncbi.nlm.nih.gov/34414254/"], ["", "", "2 cases of delayed local reactions following Moderna:https://journals.lww.com/infectdis/Fulltext/2021/07000/Delayed_Skin_Rash_After_Receiving_SARS_CoV_2_mRNA.19.aspx", "https://journals.lww.com/infectdis/Fulltext/2021/07000/Delayed_Skin_Rash_After_Receiving_SARS_CoV_2_mRNA.19.aspx"], ["", "", "4 cases of cutaneous hypersensitivity reactions following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34485656/", "https://pubmed.ncbi.nlm.nih.gov/34485656/"], ["", "", "5 Japanese cases of delayed large local reactions to Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34459023/", "https://pubmed.ncbi.nlm.nih.gov/34459023/"], ["", "", "13 cases delayed local reactions following mRNA vaccine:\u00a0https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab518/6291929", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab518/6291929"], ["", "", "COVID Vaccine arm:\u00a0https://www.psychologytoday.com/us/blog/heal-the-mind-heal-the-body/202101/what-s-the-new-phenomenon-called-covid-vaccine-arm", "https://www.psychologytoday.com/us/blog/heal-the-mind-heal-the-body/202101/what-s-the-new-phenomenon-called-covid-vaccine-arm"], ["", "", "COVID arm following Moderna: histologic features:\u00a0https://pubmed.ncbi.nlm.nih.gov/34242422/", "https://pubmed.ncbi.nlm.nih.gov/34242422/"], ["", "", "COVID arm following Moderna detected by MR neurography:\u00a0https://pubmed.ncbi.nlm.nih.gov/34746453/", "https://pubmed.ncbi.nlm.nih.gov/34746453/"], ["", "", "Covid vaccine arm may present after both mRNA vaccines vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34416053/", "https://pubmed.ncbi.nlm.nih.gov/34416053/"], ["", "", "405 cases of dermatologic reactions following Pfizer, Moderna, and Astra Zeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34254291/", "https://pubmed.ncbi.nlm.nih.gov/34254291/"], ["", "", "Erythema Migrans like rash after Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34250736/", "https://pubmed.ncbi.nlm.nih.gov/34250736/"], ["", "", "Bullous neutrophilic dermatosis with severe acral oedema post mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/35092306/"], ["", "", "Bullous Drug Eruption Rash following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34294590/", "https://pubmed.ncbi.nlm.nih.gov/34294590/"], ["", "", "Bullous eruption following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34416058/", "https://pubmed.ncbi.nlm.nih.gov/34416058/"], ["", "", "Bullous Fixed Drug Eruption following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34482558/", "https://pubmed.ncbi.nlm.nih.gov/34482558/"], ["", "", "Bullous pemphigoid triggered by covid-19 vaccine (Pfizer): rapid resolution with corticosteroid therapy:\u00a0https://pubmed.ncbi.nlm.nih.gov/34786801/", "https://pubmed.ncbi.nlm.nih.gov/34786801/"], ["", "", "Atypical erythema multiforme related to Pfizer vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34473839/", "https://pubmed.ncbi.nlm.nih.gov/34473839/"], ["", "", "Erythema multiforme after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34962029/", "https://pubmed.ncbi.nlm.nih.gov/34962029/"], ["", "", "Erythema multiforme reactions after Moderna and Pfizer: a case series: https://pubmed.ncbi.nlm.nih.gov/35097177/"], ["", "", "Generalized erythema multiforme like rash following Pfizer in a 78yoM: https://pubmed.ncbi.nlm.nih.gov/34661942/"], ["", "", "A flare up of pre-existing erythema multiforme following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33914926/"], ["", "", "Prompt onset of Rowell\u2019s syndrome following 1st dose Pfizer: https://pubmed.ncbi.nlm.nih.gov/33725406/"], ["", "", "Annular plaques mimicking Rowell\u2019s syndrome following mRNA vaccines: an overlooked phenomenon? https://pubmed.ncbi.nlm.nih.gov/34693548/"], ["", "", "Erythema multiforme following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34676438/"], ["", "", "Cutaneous adverse reactions associated with COV-2 vaccines:\u00a0https://pubmed.ncbi.nlm.nih.gov/34830627/", "https://pubmed.ncbi.nlm.nih.gov/34830627/"], ["", "", "Cutaneous adverse events related to COVID-19 vaccines: a cross-sectional questionnaire-based study of 867 patients:\u00a0https://pubmed.ncbi.nlm.nih.gov/34820975/", "https://pubmed.ncbi.nlm.nih.gov/34820975/"], ["", "", "Soft Tissue Filler Inflammatory Reaction after vaccination", "Soft Tissue Filler Inflammatory Reaction after vaccination:"], ["", "", "Immune Response to fillers and breast implants after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34174765/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34174765%2F%3Ffbclid%3DIwAR0KhH7Vmuz0trpBY400wiU2RUJZ0XTHRolMb2xwypTuOkjRCX9lvEUtc_k&h=AT22dt-JXuPry9JOK8h89ShEWHa5rx5gt4Z_hRaXoVq1UHO8RiRYz5JEksIcgLFX3KwWsBY3tq8urTsJ4C3JItTlLBNCEkOimKHNnqqwSDeFPM5fJSujY4zv14RQUcdDwedldZtf8UG2TR527xcvSQ&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Breast Implant seroma after mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34405902/", "https://pubmed.ncbi.nlm.nih.gov/34405902/"], ["", "", "L Breast Implant Capsular Contracture following Moderna vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34373851/", "https://pubmed.ncbi.nlm.nih.gov/34373851/"], ["", "", "COVID-toes after mRNA vaccination", "COVID-toes after mRNA vaccination:"], ["", "", "Systemic vasculitis in an 80yoM following mRNA vaccination demonstrated on FDG/PET:https://pubmed.ncbi.nlm.nih.gov/35175942/"], ["", "", "2 cases of Vitiligo triggered by COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35145806/"], ["", "", "Bacillus Calmette-Guerin scar erythema in a 14yoF post Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/35175660/"], ["", "", "Leukocytoclastic vasculitis:\u00a0https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41910", "https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41910?fbclid=IwAR1xS66c_vkHZQPBHewPEhlzuncgd1N-4UUsjSHpZNUoXaBdCbQBYe7HXow"], ["", "", "New onset leukocytoclastic vasculitis following COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/33928638/", "https://pubmed.ncbi.nlm.nih.gov/33928638/"], ["", "", "Leukocytoclastic vasculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/35099065/"], ["", "", "Leukocytoclastic vasculitis flare following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33928638/", "https://pubmed.ncbi.nlm.nih.gov/33928638/"], ["", "", "Leukocytoclastic vasculitis in a 42yoF after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34196469/", "https://pubmed.ncbi.nlm.nih.gov/34196469/"], ["", "", "Leukocytoclastic\u00a0vasculitis after Pfizer vaccine booster:\u00a0https://pubmed.ncbi.nlm.nih.gov/34720009/", "https://pubmed.ncbi.nlm.nih.gov/34720009/"], ["", "", "Leukocytoclastic vasculitis\u00a0in a 68yoF following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34713472/", "https://pubmed.ncbi.nlm.nih.gov/34713472/"], ["", "", "Cutaneous leukocytoclastic vasculitis induction following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34853744/", "https://pubmed.ncbi.nlm.nih.gov/34853744/"], ["", "", "Cutaneous vasculitis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34611627/", "https://pubmed.ncbi.nlm.nih.gov/34611627/"], ["", "", "Cutaneous vasculitis\u00a0following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34599716/", "https://pubmed.ncbi.nlm.nih.gov/34599716/"], ["", "", "Leukocytoclastic vasculitis as a cutaneous manifestation of the AstraZeneca vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34546608/", "https://pubmed.ncbi.nlm.nih.gov/34546608/"], ["", "", "Leukocytoclastic vasculitis after exposure to AstraZeneca vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34836739/", "https://pubmed.ncbi.nlm.nih.gov/34836739/"], ["", "", "Urticarial Vasculitis following vaccination:\u00a0https://journals.lww.com/amjdermatopathology/Citation/9000/Unique_Case_of_Urticarial_Skin_Eruptions_After.97698.aspx", "https://journals.lww.com/amjdermatopathology/Citation/9000/Unique_Case_of_Urticarial_Skin_Eruptions_After.97698.aspx"], ["", "", "Urticarial Vasculitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34369046/", "https://pubmed.ncbi.nlm.nih.gov/34369046/"], ["", "", "Small vessel vasculitis after Astra Zeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310763/", "https://pubmed.ncbi.nlm.nih.gov/34310763/"], ["", "", "Possible case\u00a0of mRNA vaccine induced small vessel vasculitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34705320/", "https://pubmed.ncbi.nlm.nih.gov/34705320/"], ["", "", "Cutaneous small vessel vasculitis following J&J:\u00a0https://pubmed.ncbi.nlm.nih.gov/34337124/", "https://pubmed.ncbi.nlm.nih.gov/34337124/"], ["", "", "Cutaneous lymphocytic vasculitis following mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34327795/", "https://pubmed.ncbi.nlm.nih.gov/34327795/"], ["", "", "Pfizer induced reactivation of varicella and resulting small vessel vasculitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310759/", "https://pubmed.ncbi.nlm.nih.gov/34310759/"], ["", "", "Granulomatous vasculitis after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34237323/", "https://pubmed.ncbi.nlm.nih.gov/34237323/"], ["", "", "Immune\u00a0complex vasculitis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34530771/", "https://pubmed.ncbi.nlm.nih.gov/34530771/"], ["", "", "Relapse of microscopic\u00a0polyangiitis after Pfizer vaccination: a case report:\u00a0https://pubmed.ncbi.nlm.nih.gov/34251683/", "https://pubmed.ncbi.nlm.nih.gov/34251683/"], ["", "", "De novo vasculitis after Moderna:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166777/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166777/"], ["", "", "2 cases of skin color discoloration following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34310755/", "https://pubmed.ncbi.nlm.nih.gov/34310755/"], ["", "", "A case series of rare cutaneous adverse events following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34363637/", "https://pubmed.ncbi.nlm.nih.gov/34363637/"], ["", "", "Moderna Vaccine Induced Skin Rash:\u00a0https://pubmed.ncbi.nlm.nih.gov/34423142/", "https://pubmed.ncbi.nlm.nih.gov/34423142/"], ["", "", "A Case series of Cutaneous vaccine reactions at Loma Linda University:\u00a0https://pubmed.ncbi.nlm.nih.gov/34423106/", "https://pubmed.ncbi.nlm.nih.gov/34423106/"], ["", "", "Reactivation of BCH vaccination scars after vaccination with mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34930152/"], ["", "", "Clinicopathological features of cutaneous reactions after mRNA vaccines, 11 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/34459036/", "https://pubmed.ncbi.nlm.nih.gov/34459036/"], ["", "", "3 cases of vesiculobullous non-IgE-mediated cutaneous reactions to Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34363258/", "https://pubmed.ncbi.nlm.nih.gov/34363258/"], ["", "", "Sweet Syndrome following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34835143/", "https://pubmed.ncbi.nlm.nih.gov/34835143/"], ["", "", "A case of generalized\u00a0sweet\u2019s syndrome with vasculitis triggered by J&J vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34849386/", "https://pubmed.ncbi.nlm.nih.gov/34849386/"], ["", "", "Bullous sweet syndrome following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34817862/", "https://pubmed.ncbi.nlm.nih.gov/34817862/"], ["", "", "A narrative review of cutaneous and hypersensitivity reactions:\u00a0https://pubmed.ncbi.nlm.nih.gov/34424434/", "https://pubmed.ncbi.nlm.nih.gov/34424434/"], ["", "", "Clinical and histopathological spectrum of delayed adverse cutaneous reactions following covid-19 vaccination, a review of 12 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/34292611/", "https://pubmed.ncbi.nlm.nih.gov/34292611/"], ["", "", "SARS-CoV-2 Vaccines and the Skin:\u00a0https://pubmed.ncbi.nlm.nih.gov/34483343/", "https://pubmed.ncbi.nlm.nih.gov/34483343/"], ["", "", "COVID-19 vaccines and cutaneous adverse reactions; a review:\u00a0https://pubmed.ncbi.nlm.nih.gov/33851937/", "https://pubmed.ncbi.nlm.nih.gov/33851937/"], ["", "", "COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide:\u00a0https://pubmed.ncbi.nlm.nih.gov/34556254/", "https://pubmed.ncbi.nlm.nih.gov/34556254/"], ["", "", "Cutaneous reactions reported after Moderna and Pfizer vaccination: a registry based study of 414 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/33838206/", "https://pubmed.ncbi.nlm.nih.gov/33838206/"], ["", "", "Response to McManon et al\u2019s\u2026414 cases:\u00a0https://pubmed.ncbi.nlm.nih.gov/34801633/", "https://pubmed.ncbi.nlm.nih.gov/34801633/"], ["", "", "Cutaneous findings\u00a0following COVID019 vaccination: review of world literature and own experience:\u00a0https://pubmed.ncbi.nlm.nih.gov/34661927/", "https://pubmed.ncbi.nlm.nih.gov/34661927/"], ["", "", "Cutaneous and allergic reactions due to covid-19 vaccinations: a review:\u00a0https://pubmed.ncbi.nlm.nih.gov/34791757/", "https://pubmed.ncbi.nlm.nih.gov/34791757/"], ["", "", "Skin reactions to covid-19 vaccines: an AAD/ILDS registry update on reaction location and COVID vaccine type:\u00a0https://pubmed.ncbi.nlm.nih.gov/34800601/", "https://pubmed.ncbi.nlm.nih.gov/34800601/"], ["", "", "Alopecia areata following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35107173/"], [], ["", "", "Ophthalmology:", "Ophthalmology:"], ["", "", "General:"], ["", "", "COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence?\u00a0https://pubmed.ncbi.nlm.nih.gov/34473193/", "https://pubmed.ncbi.nlm.nih.gov/34473193/"], ["", "", "After the storm: ophthalmic manifestations of COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34826968/", "https://pubmed.ncbi.nlm.nih.gov/34826968/"], ["", "", "Ocular adverse events after covid-19 vaccinations:\u00a0https://pubmed.ncbi.nlm.nih.gov/34559576/", "https://pubmed.ncbi.nlm.nih.gov/34559576/"], ["", "", "Ocular manifestations\u00a0after receiving COVID-19 vaccine: a systematic review:\u00a0https://pubmed.ncbi.nlm.nih.gov/34960150/", "https://pubmed.ncbi.nlm.nih.gov/34960150/"], ["", "", "Ocular adverse reactions: a review and update:\u00a0https://pubmed.ncbi.nlm.nih.gov/33865883/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/33865883/"], ["", "", "Ocular inflammatory events following COVID-19 vaccination: a multinational case series: https://pubmed.ncbi.nlm.nih.gov/34982290/"], ["", "", "Macular Neuroretinopathy:"], ["", "", "Non-arteritic anterior ischemic optic neuropathy following COVID-19 vaccination: https://pubmed."], ["", "", "Acute Macular Neuroretinopathy after AstraZeneca", "Acute Macular Neuroretinopathy after AstraZeneca:"], ["", "", "Acute macular neuroretinopathy following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34485760/", "https://pubmed.ncbi.nlm.nih.gov/34485760/"], ["", "", "Acute Central Serous Retinopathy after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34151047/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34151047%2F%3Ffbclid%3DIwAR0YcjgvrC52ak9BnneE_MSbUKZc5YkuWMAs1tLYet6pToGuhqtZHmSYI9M&h=AT2EkQzX6N4VzuGyH2GAAtPRI18KrrSR7EeimzT1dRHRRtKcv6m8kjZQrJD91fQKXV5DLcRRFMUjGY_7CYg9op_M-xBoDz30b5Z6AuG_ZSQ5vYzr-zsDmbmPp3OwCLc0WYXQY3tBKc3Vv_e5v94I6A&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "Bilateral panuveitis mimicking vogt-koyanagi-harada disease following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35113750/"], ["", "", "Panuveitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34213988/", "https://l.facebook.com/l.php?u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F34213988%2F%3Ffbclid%3DIwAR0CkN9rZANLvTW-xtXUlzzH16nd23EJDVK0c7cx5qdNCBgy8kCB5Lzz7HE&h=AT3OCxjqWYOHXcbJckWYfM9YFFGQgYpSYfAQ8dfljoJbxZ4tpx3hiMLoinUhyB_UZPI7ZKXsYOKud-GFWDRi-r02_k_Rxv1M9QlXgWiz1sI787cRLrKlvA8cGgFfBH32GtvbNOydEiAkNsbq0UPr0w&__tn__=-UK-R&c%5B0%5D=AT0BdSQPWpEXxlPS-5nK-Dg2sbyBv0qYHMkXm5u8r1iRJMLD5RJLOtAnWWxNrCAntZ3dL6U-XY3w4xLABrbwDJSCDiFm3A8hePs9aLSVY1WQ7Ol3ix679X_jX4UZur32vweHGa5d-9eoo5-JFKJJRO525wt3"], ["", "", "42 cases of Uveitis and other ocular complications following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34945256/"], ["", "", "Reduction of Visual Acuity following Pfizer:\u00a0https://link.springer.com/article/10.1007/s00011-021-01476-9?fbclid=IwAR3zAvenOwPAZmuVsx9CM7bFwOliHerfJK3M3nQCMe-3BWoT4QdNCWK7cNo", "https://link.springer.com/article/10.1007/s00011-021-01476-9?fbclid=IwAR3zAvenOwPAZmuVsx9CM7bFwOliHerfJK3M3nQCMe-3BWoT4QdNCWK7cNo"], ["", "", "Corneal Graft Rejection:"], ["", "", "Corneal graft rejection after Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34426655/", "https://pubmed.ncbi.nlm.nih.gov/34426655/"], ["", "", "Corneal graft rejection following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34835205/", "https://pubmed.ncbi.nlm.nih.gov/34835205/"], ["", "", "Acute corneal graft endothelial graft rejection following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34281760/", "https://pubmed.ncbi.nlm.nih.gov/34281760/"], ["", "", "Full thickness corneal transplant rejection 3 days following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34690266/", "https://pubmed.ncbi.nlm.nih.gov/34690266/"], ["", "", "2 cases of corneal graft rejection following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33910885/", "https://pubmed.ncbi.nlm.nih.gov/33910885/"], ["", "", "2 cases of corneal graft rejection following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34029238/", "https://pubmed.ncbi.nlm.nih.gov/34029238/"], ["", "", "4 cases of Corneal graft rejection following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34620770/", "https://pubmed.ncbi.nlm.nih.gov/34620770/"], ["", "", "Corneal graft rejection following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34827040/", "https://pubmed.ncbi.nlm.nih.gov/34827040/"], ["", "", "Retinal vein occlusion following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35113504/"], ["", "", "Combined central retinal artery and vein occlusion with ischemic optic neuropathy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/35079224/"], ["", "", "Central retinal artery occlusion after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/35088861/"], ["", "", "Bilateral Retinal Detachments 10 days after mRNA vaccination 22yoF :\u00a0https://www.jem-journal.com/article/S0736-4679(21)00611-9/fulltext", "https://www.jem-journal.com/article/S0736-4679(21)00611-9/fulltext"], ["", "", "Exacerbation of branch retinal vein occlusion post Pfizer: https://pubmed.ncbi.nlm.nih.gov/34918688/"], ["", "", "CMV reactivation and pericarditis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35116025/"], ["", "", "Vein Occlusion / Retinal Necrosis"], ["", "", "6 cases of retinal vascular events following Pfizer, Moderna, AstraZeneca vaccination:https://pubmed.ncbi.nlm.nih.gov/34835280/", "https://pubmed.ncbi.nlm.nih.gov/34835280/"], ["", "", "Central Retinal Vein Occlusion occurring immediately after 2nd\u00a0dose of mRNA vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34426861/", "https://pubmed.ncbi.nlm.nih.gov/34426861/"], ["", "", "Central vein occlusion after mRNA vaccination: a case report:\u00a0https://pubmed.ncbi.nlm.nih.gov/34571653/", "https://pubmed.ncbi.nlm.nih.gov/34571653/"], ["", "", "Combined central retinal artery and vein occlusion shortly after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34791479/", "https://pubmed.ncbi.nlm.nih.gov/34791479/"], ["", "", "Acute retinal necrosis associated with reactivation of varicella zoster virus after Pfizer vaccination in 78yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34802376/", "https://pubmed.ncbi.nlm.nih.gov/34802376/"], ["", "", "Acute retinal necrosis associated with reactivation of varicella zoster virus after Pfizer vaccination in 62yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34851795/", "https://pubmed.ncbi.nlm.nih.gov/34851795/"], ["", "", "Acute retinal necrosis associated with reactivation of varicella zoster virus after Pfizer vaccination in 71yoM:\u00a0https://pubmed.ncbi.nlm.nih.gov/34541931/", "https://pubmed.ncbi.nlm.nih.gov/34541931/"], ["", "", "Oculomotor Palsy"], ["", "", "Transient Oculomotor palsy following mRNA. Vaccine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34369471/", "https://pubmed.ncbi.nlm.nih.gov/34369471/"], ["", "", "Anterior Uveitis "], ["", "", "Anterior Uveitis following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34289406/", "https://pubmed.ncbi.nlm.nih.gov/34289406/"], ["", "", "21 cases of Uveitis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34369440/", "https://pubmed.ncbi.nlm.nih.gov/34369440/"], ["", "", "Optic Neuropathy"], ["", "", "A case of bilateral arteritic anterior ischemic optic neuropathy and a case of bilateral acute zonal occult outer retinopathy after mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34394876/", "https://pubmed.ncbi.nlm.nih.gov/34394876/"], ["", "", "Herpes Keratitis"], ["", "", "Reactivation of herpes simplex keratitis following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34493563/", "https://pubmed.ncbi.nlm.nih.gov/34493563/"], ["", "", "Relapse of stromal herpes keratitis following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34823340/", "https://pubmed.ncbi.nlm.nih.gov/34823340/"], ["", "", "2 cases of Ipsilateral zoster opthalmicus after Moderna and Johnson and Johnson:\u00a0https://pubmed.ncbi.nlm.nih.gov/34471577/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34471577/"], ["", "", "2 cases of herpes zoster ophthalmicus following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34690265/", "https://pubmed.ncbi.nlm.nih.gov/34690265/"], ["", "", "Bilateral immune mediated keratolysis following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34483273/", "https://pubmed.ncbi.nlm.nih.gov/34483273/"], ["", "", "Other:"], ["", "", "Vaccination and Bilateral Multifocal Choroiditis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34406890/", "https://pubmed.ncbi.nlm.nih.gov/34406890/"], ["", "", "34yoM with bilateral multifocal choroiditis following 2nd\u00a0dose vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34344280/", "https://pubmed.ncbi.nlm.nih.gov/34344280/"], ["", "", "Acute painless bilateral blurring of vision following Pfizer due to Vogt-Koyanagi-Hara disease:\u00a0https://pubmed.ncbi.nlm.nih.gov/34505819/", "https://pubmed.ncbi.nlm.nih.gov/34505819/"], ["", "", "Multimodal Imaging of acute foveolitis following COVID-19 vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34797736/", "https://pubmed.ncbi.nlm.nih.gov/34797736/"], ["", "", "Eyelid erythema after Pfizer vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34426009/", "https://pubmed.ncbi.nlm.nih.gov/34426009/"], ["", "", "Transient eyelid edema following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34524252/", "https://pubmed.ncbi.nlm.nih.gov/34524252/"], ["", "", "Disc edema in one eye and central serous chorioretinopathy in the other following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34783448/", "https://pubmed.ncbi.nlm.nih.gov/34783448/"], [], ["", "", "ENT", "ENT"], ["", "", "3 cases of sudden sensorineural hearing loss following Pfizer and AstraZeneca:\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520501/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520501/"], ["", "", "3 cases of Tinnitus following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34120553/", "https://pubmed.ncbi.nlm.nih.gov/34120553/"], ["", "", "COVID-vaccine associated tinnitus: a review of VAERS: https://pubmed.ncbi.nlm.nih.gov/35096388/"], ["", "", "18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer: https://pubmed.ncbi.nlm.nih.gov/34267103/"], ["", "", "18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34267103/", "https://pubmed.ncbi.nlm.nih.gov/34267103/"], ["", "", "Tinnitus/cochleopathy following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34297133/", "https://pubmed.ncbi.nlm.nih.gov/34297133/"], ["", "", "Vestibular neuritis in a 54yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34898387/"], ["", "", "Lipschutz ulcers after AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34366434/", "https://pubmed.ncbi.nlm.nih.gov/34366434/"], [], ["", "", "ID", "ID"], ["", "", "Herpes Zoster following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34397201/", "https://pubmed.ncbi.nlm.nih.gov/34397201/"], ["", "", "Herpes Zoster reactivation following Moderna:\u00a0https://pubmed.ncbi.nlm.nih.gov/34316506/", "https://pubmed.ncbi.nlm.nih.gov/34316506/"], ["", "", "Herpes Zoster following mRNA vaccination in a patient with ankylosing spondylitis:\u00a0https://pubmed.ncbi.nlm.nih.gov/34814659/", "https://pubmed.ncbi.nlm.nih.gov/34814659/"], ["", "", "5 cases of Herpes Zoster following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35180059/"], ["", "", "Zoster meningitis after Pfizer vaccination in a 39yoF: https://pubmed.ncbi.nlm.nih.gov/35186672/"], ["", "", "1 case HSV meningitis and 2 cases herpes zoster ophthalmic following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35097240/"], ["", "", "Ramsy Hunt syndrome following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34344559/", "https://pubmed.ncbi.nlm.nih.gov/34344559/"], ["", "", "L-lysine in herpesvirus\u00a0reactivation after AstraZeneca vaccine: a minor literature review and case report:\u00a0https://pubmed.ncbi.nlm.nih.gov/34962036/", "https://pubmed.ncbi.nlm.nih.gov/34962036/"], ["", "", "A case series of Herpes Zoster following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34363717/", "https://pubmed.ncbi.nlm.nih.gov/34363717/"], ["", "", "2 cases of herpes zoster following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34428545/", "https://pubmed.ncbi.nlm.nih.gov/34428545/"], ["", "", "2 cases of herpes zoster in healthy young adults following vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34363257/", "https://pubmed.ncbi.nlm.nih.gov/34363257/"], ["", "", "3 cases of Herpes Zoster following Vaccination (Moderna and AstraZeneca):\u00a0\u00a0https://pubmed.ncbi.nlm.nih.gov/34293165/", "https://pubmed.ncbi.nlm.nih.gov/34293165/"], ["", "", "3 cases of Herpes Zoster after covid vaccination in patients with chronic urticaria being treated with cyclosporine:\u00a0https://pubmed.ncbi.nlm.nih.gov/34510694/\u00a0\u00a0", "https://pubmed.ncbi.nlm.nih.gov/34510694/"], ["", "", "4 cases of Herpes Zoster (2 pfizer, 2 astrazeneca):\u00a0https://pubmed.ncbi.nlm.nih.gov/34310754/", "https://pubmed.ncbi.nlm.nih.gov/34310754/"], ["", "", "6 cases of Herpes Zoster following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/33848321/", "https://pubmed.ncbi.nlm.nih.gov/33848321/"], ["", "", "COVID-19 vaccines and herpes infection:\u00a0https://pubmed.ncbi.nlm.nih.gov/34786482/", "https://pubmed.ncbi.nlm.nih.gov/34786482/"], ["", "", "A case of varicella-zoster virus after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34390376/", "https://pubmed.ncbi.nlm.nih.gov/34390376/"], ["", "", "Varicella zoster reactivation and mRNA vaccines as a trigger:\u00a0https://pubmed.ncbi.nlm.nih.gov/34316507/", "https://pubmed.ncbi.nlm.nih.gov/34316507/"], ["", "", "40 cases of HSV and VZV reactivation following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34487581/", "https://pubmed.ncbi.nlm.nih.gov/34487581/"], [], ["", "", "Autoimmune"], ["", "", "New-onset autoimmune phenomena post COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34957554/"], ["", "", "American College of Rheumatology Guidance for COVID-19 vaccination: theoretical risk exists for AIIRD flare and potential risk for new onset autoimmunity: https://onlinelibrary.wiley.com/doi/10.1002/art.41877"], ["", "", "Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? https://www.mdpi.com/2076-393X/9/11/1353/pdf"], ["", "", "A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination "], [], [], ["", "", "MIS-V Multisystem Inflammatory Syndrome", "Miscellaneous:"], ["", "", "MIS, Pericarditis, and HLH in a 36yoF following Astrazeneca: https://pubmed.ncbi.nlm.nih.gov/34862234/"], ["", "", "Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V):\u00a0https://pubmed.ncbi.nlm.nih.gov/34326117/", "https://pubmed.ncbi.nlm.nih.gov/34326117/"], ["", "", "Multisystem inflammatory syndrome in a 12yo male following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34978781/"], ["", "", "Multisystem inflammatory Syndrome in a 12 year old boy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34955518/"], ["", "", "MIS in a 12yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35062704/"], ["", "", "3 cases of Multisystem Inflammatory Syndrome after Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34034858/", "https://pubmed.ncbi.nlm.nih.gov/34034858/"], ["", "", "Multisystem Inflammation\u00a0in a 20yoM following Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34765984/", "https://pubmed.ncbi.nlm.nih.gov/34765984/"], ["", "", "MIS-A in a 21yoF following Moderna vaccination which was given 27 days after COVID infection:https://pubmed.ncbi.nlm.nih.gov/34954311/"], ["", "", "MIS-A in a 37yoF 10 days post 2nd Moderna COVID vaccine and 1 month from COVID infection:https://pubmed.ncbi.nlm.nih.gov/34868588/"], ["", "", "Multisystem inflammatory syndrome in children by covid-19 vaccination of adolescents in France: https://pubmed.ncbi.nlm.nih.gov/34928295/"], ["", "", "Multisystem inflammatory syndrome in a COVID-19 vaccinated adolescent female with sickle cell disease: https://pubmed.ncbi.nlm.nih.gov/34955521/"], ["", "", "Autoantibody release in children after COVID mRNA vaccination: A risk factor of multisystem inflammatory syndrome? https://pubmed.ncbi.nlm.nih.gov/34835284/"], ["", "", "MIS in a 12yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35062704/"], ["", "", "Multisystem inflammatory syndrome following COVID-19 vaccination: ignored and underdiagnosed: https://pubmed.ncbi.nlm.nih.gov/34940858/"], ["", "", "Postmortem investigation of fatalities following vaccination with COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34591186/"], ["", "", "Autopsy findings and causality relationship between death and covid-19 vaccination: a systematic review: https://pubmed.ncbi.nlm.nih.gov/34945172/"], ["", "", "MIS-C in a a male adolescent after his second dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34617315/", "https://pubmed.ncbi.nlm.nih.gov/34617315/"], ["", "", "Multisystem inflammatory syndrome in an adult following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34811978/", "https://pubmed.ncbi.nlm.nih.gov/34811978/"], ["", "", "Postvaccination MIS in an adult with no evidence of prior COVID-19 infection following AstraZeneca:\u00a0https://pubmed.ncbi.nlm.nih.gov/34852213/", "https://pubmed.ncbi.nlm.nih.gov/34852213/"], ["", "", "MIS-A in an adult woman 18 days following AstraZeneca vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34511054/", "https://pubmed.ncbi.nlm.nih.gov/34511054/"], ["", "", "MIS in a 16yoM following 1st dose mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/35187466/"], ["", "", "MIS-A in  65yoM, Pfizer vaccine induced, with polyserositis detected by FDG"], ["", "", "MIS after J&J vaccine: https://pubmed.ncbi.nlm.nih.gov/35096528/"], ["", "", "Fatal Multisystem inflammatory syndrome after 2nd\u00a0dose of Pfizer:\u00a0https://pubmed.ncbi.nlm.nih.gov/34586059/", "https://pubmed.ncbi.nlm.nih.gov/34586059/"], [], [], ["", "", "Miscellaneous"], ["", "", "A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination https://www.nejm.org/doi/full/10.1056/NEJMcibr2113694"], ["", "", "SARS\u2013CoV\u20132 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8538446/"], ["", "", "SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties - WITHOUT virus https://www.sciencedirect.com/science/article/pii/S0889159121006383"], ["", "", "Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u201cpotential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\u201d https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7833091/"], ["", "", "The BNT162b2 mRNA vaccine against SARS-COV-2 reprograms both adaptive and innate immune response:\u00a0https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1?fbclid=IwAR1MV3eNa-8MZFJb_SZqAF0ycaWrMM4u5_80cL2TA7_9C2MxyJkTjdZnMjQ", "https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1?fbclid=IwAR1MV3eNa-8MZFJb_SZqAF0ycaWrMM4u5_80cL2TA7_9C2MxyJkTjdZnMjQ"], ["", "", "Does COVID-19 RNA based vaccines put at risk of immune-mediated diseases?\u00a0https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/"], ["", "", "Adverse drug reactions from Pfizer and AstraZeneca in Saudi Arabia: https://pubmed.ncbi.nlm.nih.gov/35095267/"], ["", "", "International call for vaccine adverse reaction investigation:\u00a0https://www.researchgate.net/publication/351670290_SARS-CoV-2_mass_vaccination_Urgent_questions_on_vaccine_safety_that_demand_answers_from_international_health_agencies_regulatory_authorities_governments_and_vaccine_developers?fbclid=IwAR1Gwfel6khY8ObziHNTGZriwS0Gez0CCp8zjaHllCJ9lfceD2EkJdMKmYw", "https://www.researchgate.net/publication/351670290_SARS-CoV-2_mass_vaccination_Urgent_questions_on_vaccine_safety_that_demand_answers_from_international_health_agencies_regulatory_authorities_governments_and_vaccine_developers?fbclid=IwAR1Gwfel6khY8ObziHNTGZriwS0Gez0CCp8zjaHllCJ9lfceD2EkJdMKmYw"], ["", "", "Severe COVID-19 Vaccine (Pfizer) Side Effects are rare in older adults yet are linked with depressive symptoms", "https://pubmed.ncbi.nlm.nih.gov/34686410/"], ["", "", "Serious adverse events following immunization with AstraZeneca in India, a single center experience:\u00a0https://pubmed.ncbi.nlm.nih.gov/34804334/", "https://pubmed.ncbi.nlm.nih.gov/34804334/"], ["", "", "Adverse events with Pfizer among Korean healthcare workers:\u00a0https://pubmed.ncbi.nlm.nih.gov/34816647/", "https://pubmed.ncbi.nlm.nih.gov/34816647/"], ["", "", "Pathophysiological changes after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34697287/", "https://pubmed.ncbi.nlm.nih.gov/34697287/"], ["", "", "New-onset panic disorder following Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/35180816/"], ["", "", "Psychosis associated with COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35180812/"], ["", "", "Characteristics and outcomes of adverse events after vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34693399/", "https://pubmed.ncbi.nlm.nih.gov/34693399/"], ["", "", "Symptomology following mRNA vaccination:\u00a0https://pubmed.ncbi.nlm.nih.gov/34687733/", "https://pubmed.ncbi.nlm.nih.gov/34687733/"], ["", "", "Pfizer and AstraZeneca post-vaccination side effects among Saudi vaccinees:\u00a0https://pubmed.ncbi.nlm.nih.gov/34692740/", "https://pubmed.ncbi.nlm.nih.gov/34692740/"], ["", "", "Prevalence of severe adverse events after AstraZeneca in Togo:\u00a0https://pubmed.ncbi.nlm.nih.gov/34819146/", "https://pubmed.ncbi.nlm.nih.gov/34819146/"], ["", "", "Immune mediate\u00a0events associated with COVOD-19 disease, a review of Slovenia data:\u00a0https://pubmed.ncbi.nlm.nih.gov/34740853/", "https://pubmed.ncbi.nlm.nih.gov/34740853/"], ["", "", "Concerns for Pfizer vaccine failure to wildtype variants after Delta and vaccine induced enhanced illness, as demonstrated in a mice model:\u00a0https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1.full.pdf", "https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1.full.pdf"], ["", "", "Concerns about the lipid nanoparticle in the mRNA contributing to adverse reactions:\u00a0https://www.biorxiv.org/content/10.1101/2021.03.04.430128v1.full?fbclid=IwAR2yUJH9kAb01O2PJ46AfBvQANuGiQvZd3ROs4R8qNJF6CZ4f255hDdRsSY", "https://www.biorxiv.org/content/10.1101/2021.03.04.430128v1.full?fbclid=IwAR2yUJH9kAb01O2PJ46AfBvQANuGiQvZd3ROs4R8qNJF6CZ4f255hDdRsSY"], ["", "", "Covid-19 Vaccine Injuries \u2014 Preventing Inequities in Compensation"], ["", "", "The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory: https://pubmed.ncbi.nlm.nih.gov/34841223/"], ["", "", "2 cases of adolescents with vulvar ulcers following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35104637/"]]}